CBM 94-10
Infectious Disease Testing for Blood Transfusions
January 1975 through October 1994
1888 Citations
Prepared by
Martha H. Glock, M.L.S., National Library of Medicine
Paul R. McCurdy, M.D., National Heart, Lung, and Blood Institute
U.S. DEPARTMENT OF HEALTH
AND HUMAN SERVICES
Public Health Service
National Institutes of Health
National Library of Medicine
Reference Section
8600 Rockville Pike
Bethesda, Maryland 20894
1994
National Library of Medicine Cataloging in Publication
Glock, Martha
Infectious disease testing for blood transfusions :
January 1975 through October 1994 : 1888 citations /
prepared by Martha H. Glock, Paul R. McCurdy. -- Bethesda,
Md. (8600 Rockville Pike, Bethesda 20894) : U.S. Dept. of
Health and Human Services, Public Health Service, National
Institutes of Health, National Library of Medicine,
Reference Section; Pittsburgh, PA : Sold by the Supt. of
Docs., U.S. G.P.O., 1994.
-- (Current bibliographies in medicine ; 94-10)
Available from NLM at no cost through Internet FTP.
Prepared in support of the Consensus Development
Conference on Infectious Disease Testing for Blood
Transfusions, held on January 9-11, 1995 at the National
Institutes of Health in Bethesda, Md.
1. Blood Transfusion - bibliography 2. Communicable
Diseases - blood - bibliography 3. HIV Infections - blood -
bibliography 4. Hepatitis, Viral, Human - blood -
bibliography I. McCurdy, Paul R. II. National Library of
Medicine (U.S.). Reference Section III. Consensus
Development Conference on Infectious Disease Testing for
Blood Transfusions (1995 : National Institutes of Health)
IV. Title V. Series
02NLM: ZW 1 N272 no.94-10
SERIES NOTE
Current Bibliographies in Medicine (CBM) is a continuation in
part of the National Library of Medicine's Literature Search
Series, which ceased in 1987 with No. 87-15. In 1989 it also
subsumed the Specialized Bibliography Series. Each bibliography
in the new series covers a distinct subject area of biomedicine
and is intended to fulfill a current awareness function.
Citations are usually derived from searching a variety of online
databases. NLM databases utilized include MEDLINE, AVLINE,
BIOETHICSLINE, CANCERLIT, CATLINE, HEALTH, POPLINE and TOXLINE.
The only criterion for the inclusion of a particular published
work is its relevance to the topic being presented; the format,
ownership, or location of the material is not considered.
Comments and suggestions on this series may be addressed to:
Karen Patrias, Editor
Current Bibliographies in Medicine
Reference Section
National Library of Medicine
Bethesda, MD 20894
Phone: 301-496-6097
Fax: 301-402-1384
Internet: patrias@nlm.nih.gov
This bibliography, CBM 94-10, is the last publication in this
series for calendar year 1994.
Ordering Information:
Current Bibliographies in Medicine is sold by the Superintendent
of Documents, U.S. Government Printing Office, P.O. 371954,
Pittsburgh, PA 15250-7954. To order the entire CBM series for
calendar year 1994 (approximately 10 bibliographies), send $60.00
($75.00 foreign) to the Superintendent of Documents citing GPO
List ID: CBM94. For your convenience an order blank is given
inside the back cover. Orders for individual bibliographies in
the series ($8.50, $10.63 foreign) should be sent to the
Superintendent of Documents citing the title, CBM number, and the
GPO List ID given above.
Internet Access:
The Current Bibliographies in Medicine series is also available
at no cost to anyone with Internet access through FTP (File
Transfer Protocol). FTP to nlmpubs.nlm.nih.gov and login as
anonymous. The index file in the "bibs" directory provides
information on the bibliographies available.
Use of funds for printing this periodical has been approved by
the Director of the Office of Management and Budget through
September 30, 1994.
INFECTIOUS DISEASE TESTING FOR BLOOD TRANSFUSIONS
The determination that the AIDS virus (human immunodeficiency
virus, HIV) could be transmitted by blood transfusion focussed
public, medical, regulatory, and Congressional interest on blood
transfusion safety. Although the emergence of AIDS and the
discovery of HIV triggered the interest, hepatitis had long been
known to be transmitted by blood transfusion and to some was a
bigger threat to transfused patients. In addition to improving
the screening of donors by modifying the health history
questionnaire, six new tests have been added to two older ones
that were applied to donated blood to reduce the potential for
infectious units to escape detection and be transfused. One of
the old tests directly detects viruses or portions thereof (e.g.
HBsAG), while most of the new ones detect antibodies to viruses
(e.g., antibodies to HIV-1, HIV-2, HBcAg, HTLV-I, and HCV). The
last of the six new tests is a non-specific indicator of liver
inflammation (ALT). The utility of two of these tests (ALT and
antibodies to HBcAg) has been questioned, as has been the value
of a long-used test, the serological test for syphilis. Because
of concern that some of these tests may have outlived their
usefulness, that resources are being wasted and that extra tests
mean some extra human errors, the National Institutes of Health
sponsored a Consensus Development Conference on Infectious
Disease Testing for Blood Transfusions.
This bibliography was prepared to support this Conference, held
on January 9-11, 1995 at the National Institutes of Health in
Bethesda, MD. Because the concept of surrogate testing for
hepatitis was developed in the mid-to-late 1970's, an attempt was
made to include key articles and papers back to 1975. The number
of articles that have addressed infectious disease testing of
donated blood is so large, however, that it has been necessary to
be selective. For example, the relationship between surrogate
tests such as ALT and antibodies to HBcAg and non-A, non-B
hepatitis or HIV infection is likely to be different in parts of
Europe and in Asia, Africa, and South America than in the United
States. Accordingly the list does not include many papers that
report studies done in those areas. In particular, no articles
in a language other than English have been included if they were
published before 1990. Some books and book chapters have been
included, but the bibliography primarily consists of journal
articles and conference papers and abstracts. Unfortunately, in
the selection process some worthy papers may have been
overlooked. The bibliography is arranged by disease or virus
tested for, and citations appear in only one category, although
it is recognized that some of the tests relate to more than one
transfusion-transmitted disease.
SEARCH STRATEGY
A variety of online databases are usually searched in preparing
bibliographies in the CBM series. To assist you in updating or
otherwise manipulating the material in this search, the strategy
used for the NLM's MEDLINE database is given below. Please note
that the search strategies presented here differ from individual
demand searches in that they are generally broadly formulated and
irrelevant citations edited out prior to printing.
SS 1 = BLOOD TRANSFUSION OR BLOOD DONORS OR BLOOD BANKS OR
EXCHANGE TRANSFUSION, WHOLE BLOOD OR ERYTHROCYTE TRANSFUSION OR
BLOOD COMPONENT TRANSFUSION
SS 2 = (TW) INFECTIOUS AND ALL DISEASE# OR COMMUNICABLE AND ALL DISEASE#
SS 3 = 1 AND 2
SS 4 = COMMUNICABLE DISEASES
SS 5 = EXP HEPATITIS, VIRAL, HUMAN OR EXP HEPATITIS VIRUSES
SS 6 = EXP HEPATITIS ANTIBODIES OR EXP HEPATITIS B ANTIGENS
SS 7 = EXP HIV OR HIV ANTIBODIES OR EXP HIV ANTIGENS OR EXP HIV INFECTIONS
SS 8 = EXP SYPHILIS OR EXP CHAGAS DISEASE OR EXP LYME DISEASE
SS 9 = BABESIOSIS OR BARTONELLA OR BARTONELLA INFECTIONS
SS 10 = EXP PARVOVIRIDAE OR EXP PARVOVIRIDAE INFECTIONS
SS 11 = VIREMIA OR BACTEREMIA OR FUNGEMIA
SS 12 = 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11
SS 13 = 1 AND 12
SS 14 = ALANINE AMINOTRANSFERASE/BLOOD OR MASS SCREENING
SS 15 = 14 AND EXP BLOOD TRANSFUSIONS
SS 16 = 3 OR 13 OR 15
GRATEFUL MED
To make online searching easier and more efficient, the Library
offers GRATEFUL MED, microcomputer-based software that provides a
user-friendly interface to most NLM databases. This software was
specifically developed for health professionals and features
multiple choice menus and "fill in the blank" screens for easy
search preparation. GRATEFUL MED runs on an IBM PC (or IBM-
compatible) with DOS 2.0 or a Macintosh, and requires a Hayes (or
Hayes-compatible) modem. It may be purchased from the National
Technical Information Service in Springfield, Virginia, for
$29.95 (plus $3.00 per order for shipping). For your
convenience, an order blank has been enclosed at the back of this
bibliography.
SAMPLE CITATIONS
Citations in this bibliographic series are formatted according to
the rules established for Index Medicus. Sample journal and
monograph citations appear below. For journal articles written
in a foreign language, the English translation of the title is
placed in brackets; for monographs, the title is given in the
original language. In both cases the language of publication is
shown by a three letter abbreviation appearing at the end of the
citation. Note also that a colon (:) may appear within an
author's name or article title. The NLM computer system
automatically inserts this symbol in the place of a diacritical
mark.
Journal Article:
Authors Article Title
Barbara JA, Tegtmeier GE. Cytomegalovirus and blood
transfusion. Blood Rev 1987 Sep;1(3):207-11.
Abbreviated Journal Date Volume Issue Pages
Title
Monograph:
Authors/Editors Title
Smith DM, Carlson KB, editors. Current scientific/ethical
dilemmas in blood transfusion.
Arlington (VA): American Association of Blood Banks; 1987. 113 p.
Place of Publisher Date Total
Publication Pages
_________________________________
*For details of the formats used for references, see the
following publication:
Patrias, Karen. National Library of Medicine recommended formats
for bibliographic citation. Bethesda (MD): The Library; 1991
Apr. Available from: NTIS, Springfield, VA; PB91-182030.
TABLE OF CONTENTS
General
AIDS/HIV/HTLV
Babesiosis
Bacteremia
Chagas Disease
Cytomegalovirus
Hepatitis
Lyme Disease
Parvovirus
Syphilis and Other Sexually Transmitted Diseases (Other than
AIDS/HIV/HTLV)
Other Diseases
General
Adoumie R, Lockanathan R, Yen A, Chiu RC. Character of shed
blood in cardiac and thoracic surgery patients: implications for
reinfusion. Can J Surg 1994 Jun;37(3):203-7.
AuBuchon JP, Dodd RY. Analysis of the relative safety of
autologous blood units available for transfusion to homologous
recipients. Transfusion 1988 Sep-Oct;28(5):403-5. Comment in:
Transfusion 1989 May;29(4):373-5.
Beauregard P, Blajchman MA. Hemolytic and pseudo-hemolytic
transfusion reactions: an overview of the hemolytic transfusion
reactions and the clinical conditions that mimic them. Transfus
Med Rev 1994 Jul;8(3):184-99.
Brunko P. [Regulation of drugs derived from human blood and
plasma in the European Community]. Rev Fr Transfus Hemobiol 1992
Dec;35(6):425-8. (Fre).
Buraia TL, Butakov AA, Drozhennikov VA, Nikulin VN, Pinegin BV,
Iushchuk ND. [Changes in the myeloperoxidase and acid
phosphatase activities in human peripheral blood neutrophils with
the cells stimulated in vitro]. Zh Mikrobiol Epidemiol
Immunobiol 1991 Oct;(10):52-5. (Rus).
Busch MP, Guiltinan A, Skettino S, Cordell R, Zeger G, Kleinman
S. Safety of blood donations following a natural disaster.
Transfusion 1991 Oct;31(8):719-23.
Carmel R, Shulman IA. Blood transfusion in medically treatable
chronic anemia. Pernicious anemia as a model for transfusion
overuse. Arch Pathol Lab Med 1989 Sep;113(9):995-7.
Cernescu C, Cristea A, Deutsch I. [The improvement of a
serological screening method in blood transfusion]. Rev Roum
Virol 1990 Jul-Dec;41(3-4):181-95. (Fre).
Chen HS, Yang ZH. Perfluorocarbon as blood substitute in
clinical applications and in war casualties. Biomater Artif
Cells Artif Organs 1988;16(1-3):403-9.
Corcoran E. The burden of proof. Donated blood runs a costly
gauntlet of tests. Sci Am 1989 Apr;260(4):79-80.
Eckert RD, Wallace EL. Securing a safer blood supply: two views.
Washington: American Enterprise Institute for Public Policy
Research; 1985. 153 p.
Gargouri J, Brunot A, Souissi T. [Infection control safety in
blood transfusions]. Tunis Med 1993 Feb;71(2):63-70. (Fre).
Gimble J, Kline L, Friedman LI. Evaluation of technical and
behavioral issues in predonation alanine aminotransferase
testing. Transfusion 1989 Sep;29(7):584-9.
Heim MU, Mempel W. [The need for thorough infection screening in
donors of autologous blood]. Beitr Infusionther 1991;28:313-6.
(Ger).
Heiss MM, Mempel W, Delanoff C, Mempel M, Jauch KW, Schildberg
FW. [Clinical effects of blood transfusion-associated immune
modulation on outcome of tumor surgery]. Infusionsther
Transfusionsmed 1993 Jun;20 Suppl 2:25-9. (Ger).
Hume HA, Ali AM, Decary F, Blajchman MA. Evaluation of pediatric
transfusion practice using criteria maps. Transfusion 1991
Jan;31(1):52-8.
Kruskall MS, Popovsky MA, Pacini DG, Donovan LM, Ransil BJ.
Autologous versus homologous donors. Evaluation of markers for
infectious disease. Transfusion 1988 May-Jun;28(3):286-8.
Lanzer G, Beyer J, Weisshaar D. [Walkaway systems in general
practice: Behring ELISA Processor III]. Beitr Infusionther
1993;31:218-23. (Ger).
Laske A, Carrel T, Bauer E, Schonbeck M, Schmid ER, von Segesser
LK, Turina M. [Blood transfusion and reducing the need for blood
in heart transplantation]. Helv Chir Acta 1991 May;57(6):883-8.
(Ger).
Lennon RL, Hosking MP, Gray JR, Klassen RA, Popovsky MA, Warner
MA. The effects of intraoperative blood salvage and induced
hypotension on transfusion requirements during spinal surgical
procedures. Mayo Clin Proc 1987 Dec;62(12):1090-4.
Love TR, Hendren WG, O'Keefe DD, Daggett WM. Transfusion of
predonated autologous blood in elective cardiac surgery. Ann
Thorac Surg 1987 May;43(5):508-12.
Mallory D, Malamut D, Sandler SG. A decade of rare donor
services in the United States. Report of the American Red Cross
Rare Donor Registry (1981-1990). Vox Sang 1992;63(3):186-91.
Mallouh AA, Asha M. Beneficial effect of blood transfusion in
children with sickle cell chest syndrome. Am J Dis Child 1988
Feb;142(2):178-82.
McBride JA, O'Hoski P, Barnes CC, Spiak C, Blajchman MA. Rhesus
alloimmunization following intensive plasma exchange.
Transfusion 1983 Jul-Aug;23(4):352-4.
Mortimer PP. Blood donor screening: benefits and costs
[editorial]. Br J Hosp Med 1992 Oct 7-20;48(7):356-7.
Popovsky MA, Devine PA, Taswell HF. Intraoperative autologous
transfusion. Mayo Clin Proc 1985 Feb;60(2):125-34.
Quartier P, Floch C, Meier F, Fruchart MF, Brossard Y, Lejeune C.
[Massive fetomaternal hemorrhage and prevention of fetomaternal
Rhesus incompatibility. The failure of our present system of
prevention]. J Gynecol Obstet Biol Reprod (Paris)
1993;22(5):517-9. (Fre).
Reesink HW, Nydegger UE, Tegtmeier GE, Barbara J, Seidl S,
Woodfield DG, Okochi K, Courouce AM, Van der Poel CL. Blood
donor screening or `over-screening': how far to go in avoiding
transmission of infectious agents? [editorial]. Vox Sang
1992;63(1):59-69.
Rosen A, Klein M, Beck A. [Follow-up in HELLP syndrome].
Zentralbl Gynakol 1990;112(5):273-7. (Ger).
Safi MA, Ghaznawi HT, Arafa MS, Moselhi M. An immunoserological
study among blood donors of Makkah region, Saudi Arabia. J Egypt
Soc Parasitol 1989 Jun;19(1):91-9.
Schmidt PJ. Introducing new tests before transfusion. Who shall
decide? Arch Pathol Lab Med 1994 Apr;118(4):454-6.
Seltzer DG, Brown MD, Tompkins JS, Enger I, Cammisa FP Jr.
Toward the elimination of homologous blood use in elective lumbar
spine surgery. J Spinal Disord 1993 Oct;6(5):412-21.
Sherwood WC. Donor deferral registries. Transfus Med Rev 1993
Apr;7(2):121-8.
Shulman IA, Saxena S, Nelson JM. The impact of alanine
aminotransferase testing on Hispanic blood donations. Arch
Pathol Lab Med 1987 Oct;111(10):988-9.
Soloway HB, Kaplan HS. Mathematical implications of inadvertent
sample swapping and the perception of apparent rates of gross
error [letter]. Clin Chem 1990 Aug;36(8 Pt 1):1525-6.
Sorace JM, Carnahan GE, Moore GW, Berman JJ. Automated review of
blood donor screening test patterns at a regional blood center.
Am J Clin Pathol 1992 Sep;98(3):334-44.
Sridhara S, Clarke BJ, Ofosu FA, High KA, Blajchman MA. The
direct binding of human factor VII in plasma to recombinant human
tissue factor. Thromb Res 1993 May 15;70(4):307-16.
Strauss RG, Levy GJ, Sotelo-Avila C, Albanese MA, Hume H, Schloz
L, Blazina J, Werner A, Barrasso C, Blanchette V, et al.
National survey of neonatal transfusion practices: II. Blood
component therapy. Pediatrics 1993 Mar;91(3):530-6.
Toy PT, Stehling LC, Strauss RG, Esposito B, Huling D, Poole L,
Sears R. Underutilization of autologous blood donation among
eligible elective surgical patients. Am J Surg 1986
Nov;152(5):483-6.
Vorob'ev AI, Dabberkha NM. [The problems of modern transfusion
science]. Ter Arkh 1991;63(7):4-9. (Rus).
Wagner SJ, Bardossy L, Moroff G, Dodd RY, Blajchman MA.
Assessment of the hemostatic effectiveness of human platelets
treated with aminomethyltrimethyl psoralen and UV A light using a
rabbit ear bleeding time technique. Blood 1993 Dec
1;82(11):3489-92.
Watanabe J. [Laboratory tests in Japanese Red Cross Blood
Centers to prevent transfusion-transmitted diseases]. Rinsho
Byori 1991 Mar;Suppl 88:60-9. (Jpn).
Weissauer W, Opderbecke HW. [Preoperative patient education
about transfusion risks--medico-legal considerations of a BGH
decision]. Chirurg 1993 Oct;64(10 Suppl):199-205. (Ger).
Weisshaar D. [Experiences with the ES-600 equipment]. Beitr
Infusionther 1993;31:215-7. (Ger).
Willett DE. The duty to warn about transfusion risks. Arch
Pathol Lab Med 1989 Mar;113(3):307-10.
Williams KM, Williams AE, Kline LM, Dodd RY. Stability of serum
alanine aminotransferase activity. Transfusion 1987 Sep-
Oct;27(5):431-3.
Wun T, Paglieroni T, Holland P. Prolonged circulation of
activated platelets following plasmapheresis. J Clin Apheresis
1994;9(1):10-6.
AIDS/HIV/HTLV
The acquired immunodeficiency syndrome. Commentary. Council on
Scientific Affairs. JAMA 1984 Oct 19;252(15):2037-43.
[Acquired immunodeficiency syndrome (AIDS)]. Wkly Epidemiol Rec
1990 Feb 23;65(8):56-7. (Fre).
[Acquired immunodeficiency syndrome (AIDS). Surveillance of HIV-2
infection in blood donors, 1987-1989]. Wkly Epidemiol Rec 1991
Mar 22;66(12):84-5. (Fre).
[Acquired immunodeficiency syndrome (AIDS). Surveillance update
to 30 September 1989 in the WHO European Region]. Wkly Epidemiol
Rec 1990 Feb 2;65(5):31-4. (Fre).
[Acquired immunodeficiency syndrome (AIDS) and sexually
transmitted diseases]. Wkly Epidemiol Rec 1991 Aug
16;66(33):243-6. (Fre).
Adams M, Lee TH, Busch MP, Heitman J, Marshall GJ, Gjerset GF,
Mosley JW. Rapid freezing of whole blood or buffy coat samples
for polymerase chain reaction and cell culture analysis:
application to detection of human immunodeficiency virus in blood
donor and recipient repositories. The Transfusion Safety Study
Group. Transfusion 1993 Jun;33(6):504-8.
Adler WH, Nagel JE. Acquired immunodeficiency syndrome in the
elderly. Drugs Aging 1994 May;4(5):410-6.
Aledort LM. AIDS: an update. Hosp Pract (Off Ed) 1983
Sep;18(9):159-65, 169-71.
Aledort LM. Blood products and immune changes: impacts without
HIV infection. Semin Hematol 1988 Apr;25(2 Suppl 1):14-9.
Aledort LM, Hilgartner MW, Pike MC, Gjerset GF, Koerper MA, Lian
EY, Lusher JM, Mosley JW. Variability in serial CD4 counts and
relation to progression of HIV-I infection to AIDS in haemophilic
patients. Transfusion Safety Study Group. BMJ 1992 Jan
25;304(6821):212-6.
Aledort LM, Operskalski EA, Dietrich SL, Koerper MA, Gjerset GF,
Lusher JM, Lian EC, Mosley JW. Low CD4+ counts in a study of
transfusion safety. The Transfusion Safety Study Group [letter].
N Engl J Med 1993 Feb 11;328(6):441-2. Published erratum appears
in N Engl J Med 1993 Apr 15;328(15):1128. Comment in: N Engl J
Med 1993 Feb 11;328(6):429-31.
Alfurayh O, Sobh M, Buali A, Ali MA, Barri Y, Qunibi W, Taher S.
Hepatitis C virus infection in chronic haemodialysis patients, a
clinicopathologic study. Nephrol Dial Transplant
1992;7(4):327-32. Comment in: Nephrol Dial Transplant
1992;7(12):1259-60.
Allain JP. Prevalence of HTLV-III/LAV antibodies in patients
with hemophilia and in their sexual partners in France [letter].
N Engl J Med 1986 Aug 21;315(8):517-8.
Allen UD, Guerriere M, Read SE, Detsky AS. Percutaneous injuries
among health care workers. The real value of human
immunodeficiency virus testing of `donor' blood. Arch Intern Med
1991 Oct;151(10):2033-40.
Almond B. AIDS - a moral issue: the ethical, legal and social
aspects. New York: St. Martin's Press; 1990. 186 p.
Alter HJ, Eichberg JW, Masur H, Saxinger WC, Gallo R, Macher AM,
Lane HC, Fauci AS. Transmission of HTLV-III infection from human
plasma to chimpanzees: an animal model for AIDS. Science 1984
Nov 2;226(4674):549-52.
Alter HJ, Epstein JS, Swenson SG, VanRaden MJ, Ward JW, Kaslow
RA, Menitove JE, Klein HG, Sandler SG, Sayers MH, et al.
Prevalence of human immunodeficiency virus type 1 p24 antigen in
U.S. blood donors--an assessment of the efficacy of testing in
donor screening. The HIV-Antigen Study Group. N Engl J Med 1990
Nov 8;323(19):1312-7. Comment in: N Engl J Med 1991 Oct
17;325(16):1174-5.
AMA guidelines: counseling of HIV-seropositive transfusion
recipients. Minn Med 1987 Aug;70(8):437-8.
American Medical Association, Board of Trustees. AMA HIV policy
update: report X (I-89). Chicago: The Association; 1989 Dec. 26
p.
Anderson DW, Epstein JS, Lee TH, Lairmore MD, Saxinger C,
Kalyanaraman VS, Slamon D, Parks W, Poiesz BJ, Pierik LT, et al.
Serological confirmation of human T-lymphotropic virus type I
infection in healthy blood and plasma donors. Blood 1989 Nov
15;74(7):2585-91.
Anderson KC, Gorgone BC, Marlink RG, Ferriani R, Essex ME, Benz
PM, Groopman JE. Transfusion-acquired human immunodeficiency
virus infection among immunocompromised persons. Ann Intern Med
1986 Oct;105(4):519-27.
Anderson LJ. The AIDS crisis and the medical-legal implications
of transfusion therapy. ANNA J 1991 Jun;18(3):291-4, 322.
Andes WA, Daul CB, deShazo RD, Palmer CH. Seroconversion to
human immunodeficiency virus (HIV) in hemophiliacs. Relation to
lymphadenopathy. Transfusion 1988 Mar-Apr;28(2):98-102.
Andreu J, Abad MA, Sanchez-Quijano A, Torronteras R, Luque F,
Garcia de las Heras J, Soto B, Pineda JA, Leal M, Lissen E. High
rate of nonspecific anti-hepatitis C reactivity amongst
homosexual men in comparison with that found in other sexually
active groups and blood donors. Viral Hepatitis and AIDS Study
Group. J Intern Med 1994 Jul;236(1):73-7.
Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon
L. New evidence on intravenous cocaine use and the risk of
infection with human immunodeficiency virus type 1. Am J
Epidemiol 1991 Nov 15;134(10):1175-89.
Aronson DL. Infection of hemophiliacs with HIV. J Clin Apheresis
1993;8(2):117-9.
Aronson DL. Regulation and licensing of U.S. plasma products:
response to AIDS. Dev Biol Stand 1987;67:215-20.
Ashton LJ, Learmont J, Luo K, Wylie B, Stewart G, Kaldor JM. HIV
infection in recipients of blood products from donors with known
duration of infection. Lancet 1994 Sep 10;344(8924):718-20.
Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The
trading of sex for drugs or money and HIV seropositivity among
female intravenous drug users. Am J Public Health 1994
Mar;84(3):382-7.
Atlas SJ, Singer DE, Skates SJ. Changing blood use in the AIDS
era: the case of elective hip surgery. Transfusion 1994
May;34(5):365-7.
Aubert V, Wauters JP, Schneider P, Chave JP, Frei PC. Follow-up
of HIV-1 seroconversion in a dialysed patient infected by an
`HIV-negative' blood unit [letter]. AIDS 1990 Sep;4(9):929-30.
Ayala A, Rodriguez C, Belliard M, Perez J, Khoury E. Prevalence
of HIV infection in blood donors [abstract]. Int Conf AIDS 1993
Jun 6-11;9(2):739.
Ayres L, Avillez F, Garcia-Benito A, Deinhardt F, Gurtler L,
Denis F, Leonard G, Ranger S, Grob P, Joller-Jemelka H, et al.
Multicenter evaluation of a new recombinant enzyme immunoassay
for the combined detection of antibody to HIV-1 and HIV-2. AIDS
1990 Feb;4(2):131-8.
Backer U, Gathof A, Howe J, Strobel E, Deinhardt F, Gurtler L,
Grob P, Joller-Jemelka H, Kuhnl P, Seidl S, et al. A new second-
generation anti-HIV-1 enzyme immunoassay using recombinant
envelope and core proteins. AIDS 1988 Dec;2(6):477-80.
Baecker U, Weinauer F, Michel P, Weise W. HIV antigen screening
in blood donors [abstract]. Int Conf AIDS 1993 Jun
6-11;9(2):739.
Baker AF. Liability without fault and the AIDS plague compel a
new approach to cases of transfusion-transmitted disease. Spec
Law Dig Health Care (Mon) 1991 Aug;(150):7-470.
Balfour HH Jr. Transfusion and the human immunodeficiency virus
[editorial]. Transfusion 1993 Feb;33(2):101-2. Comment on:
Transfusion 1993 Feb;33(2):111-8.
Ballem P, Buskard N, Elliot M, Adatia A. Review of the British
Columbia Canada CRCBTS lookback program for HIV-positive blood
donors [abstract]. Clin Invest Med 1988;11(4 Suppl):C54.
Ballester OF, Abdallah JM, Prasad AS. Lymphocyte subpopulation
abnormalities in sickle cell anemia: a distinctive pattern from
that of AIDS. Am J Hematol 1986 Jan;21(1):23-7.
Barak M, Merzbach D, Gruener N. Neopterin measured in serum and
tissue culture supernates by a competitive enzyme-linked
immunosorbant assay. Clin Chem 1989 Jul;35(7):1467-71.
Barbara JA. Challenges in transfusion microbiology. Transfus
Med Rev 1993 Apr;7(2):96-103.
Barbara JA, Contreras M. Hepatitis C virus screening: UK Blood
Transfusion Service on the threshold. Med Lab Sci 1991
Jul;48(3):171-4.
Barbara JA, Garson JA. Polymerase chain reaction and transfusion
microbiology. Vox Sang 1993;64(2):73-81.
Barbara JA, Tedder RS. Viral infections transmitted by blood and
its products. Clin Haematol 1984 Oct;13(3):693-707.
Barrett JE, Dawson G, Heller J, Bairstow C, Fico R, Webber JS,
Gutierrez R, Decker RH. Performance evaluation of the Abbott
HTLV III EIA, a test for antibody to HTLV III in donor blood. Am
J Clin Pathol 1986 Aug;86(2):180-5.
Barry MJ, Cleary PD, Fineberg HV. Screening for HIV infection:
risks, benefits, and the burden of proof. Law Med Health Care
1986 Dec;14(5-6):259-67.
Baruch A, Masci J, Schechter C, Nicholas P. Prevalence and
presenting characteristics of hiv patients 60 years and older
[abstract]. Int Conf AIDS 1992 Jul 19-24;8(2):C246.
Battery claim allowed for alleged failure to use family-donated
blood. J Health Hosp Law 1991 Oct;24(10):327-8.
Battjes RJ, Pickens RW, Amsel Z. Introduction of HIV infection
among intravenous drug abusers in low prevalence areas. J Acquir
Immune Defic Syndr 1989;2(6):533-9.
Baumgarten K, Chiewsilp P, Gilcher R, Gurtler L, Hampl H, Henrard
D, Holzberger G, Jullien AM, Kuhnl P, Matthes G, et al.
[Comments on HIV antigen screening of blood donors].
Infusionsther Transfusionsmed 1993 Jun;20(3):96-8. (Ger).
Bayer R. AIDS and liberalism: a response to Patricia
Illingworth. Bioethics 1992 Jan;6(1):23-7.
Bayer R. Gays and the stigma of bad blood. Hastings Cent Rep
1983 Apr;13(2):5-7.
Bayer R. Private acts, social consequences: AIDS and the
politics of public health. New York: Free Press; 1989. 282 p.
Bayer R, Levine C, Murray TH. Guidelines for confidentiality in
research on AIDS. AIDS Res 1983-84;1(4):275-97.
Bayer R, Levine C, Wolf SM. HIV antibody screening: an ethical
framework for evaluating proposed programs. JAMA 1986 Oct
3;256(13):1768-74.
Beal RW, van Aken WG. Gift or good? A contemporary examination
of the voluntary and commercial aspects of blood donation. Vox
Sang 1992;63(1):1-5. Comment in: Vox Sang 1993;65(2):165-6.
Bencivelli F. [HIV infection and blood transfusion.] G Mal
Infett Parassit 1988;40(11):1139-41. (Ita).
Berkelman RL, Heyward WL, Stehr-Green JK, Curran JW.
Epidemiology of human immunodeficiency virus infection and
acquired immunodeficiency syndrome. Am J Med 1989 Jun;86(6 Pt
2):761-70. Comment in: Am J Med 1989 Oct;87(4):489.
Berkman SA, Groopman JE. Transfusion associated AIDS. Transfus
Med Rev 1988 Mar;2(1):18-28.
Berteau F, Mention J, Tissedre J, Narraido B, Grall C,
Glowaczover E, Keita A, Laval Y, Bedjabaga I, Ossari S.
[Evaluation of the seroprevalence of human immunodeficiency virus
(HIV) and human t-cell lymphotropic virus (HTLV) in Haut Ogooue
Province in Gabon in pregnant women and blood donor control
groups]. Bull Soc Pathol Exot 1993;86(1):12-5. (Fre).
Biggar RJ, Rosenberg PS. HIV infection/AIDS in the United States
during the 1990s. Clin Infect Dis 1993 Aug;17 Suppl 1:S219-23.
Blaxhult A, Granath F, Lidman K, Giesecke J. The influence of
age on the latency period to AIDS in people infected by HIV
through blood transfusion. AIDS 1990 Feb;4(2):125-9.
Blood issues update: minimizing the risk of transfusion-
associated HIV infection. American Hospital Association Technical
Advisory Task Force on Blood Resources. Hosp Technol Ser 1989
Aug;8(21):1-14.
Bonanni G, D'Ambrosio F, Marino S. [HIV and other retroviruses
in the screening of blood donors (letter)]. Recenti Prog Med
1991 Feb;82(2):122-4. (Ita).
Borzini P. [Platelet immunology: diagnostic aspects of
thrombocytopenia]. Haematologica 1991 Jun;76 Suppl 3:116-23.
(Ita).
Bouchard I, Espinoza P, Stein S, Polo DeVoto J, D'Havillivillee
P, Benamouzig R. [Hospital visits and HIV infection in the
prison environment (abstract)]. Int Conf AIDS 1989;5:81. (Fre).
Bourquelot P, Oksenhendler E, Wolff M, Fegueux S, Piketty C,
D'Agay MF, Clauvel JP. [Hemophagocytic syndrome in HIV
infection]. Presse Med 1993 Sep 11;22(26):1217-20. (Fre).
Bove JR. The response to AIDS [editorial]. Transfusion 1985
Jan-Feb;25(1):1-2.
Bove JR. Testing in the years ahead: new pressures and new
concerns. Transfusion 1990 Jan;30(1):63-7.
Bove JR. Transfusion-associated hepatitis and AIDS. What is the
risk? N Engl J Med 1987 Jul 23;317(4):242-5.
Bove JR. Transfusion-transmitted diseases: current problems and
challenges. Prog Hematol 1986;14:123-47.
Bove JR, Dodd RY, Miller WV, Sandler SG. How should we handle
the ethical questions regarding information to donors and
patients and the practical implications regarding deferral of
donors and handling of donated blood in the event of introducing
a screening test for HTLV-III as in order to prevent transmission
of AIDS by blood transfusion? [clinical conference]. Vox Sang
1985;49(3):234-9.
Brady MT, Cuartas JF. HIV infection of multiply-transfused
pediatric oncology patients in a low-prevalence area. Am J
Pediatr Hematol Oncol 1992 Aug;14(3):233-5.
Brady MT, Ng A. Protection of neonates from transfusion-
associated AIDS by the use of CMV-seronegative blood before
availability of specific serologic tests for HTLV-III (HIV). Am
J Perinatol 1987 Oct;4(4):305-7.
Brauer P, Wullenweber J, Sibrowski W. [HIV: how great is the
residual risk? (letter)]. Dtsch Med Wochenschr 1994 May
13;119(19):715-6. (Ger).
Brinchmann JE. [Factors influencing the development of the HIV
pandemic]. Tidsskr Nor Laegeforen 1992 Jun 30;112(17):2231-4.
(Nor).
Brownlee RG, Sunzeri FJ, Busch MP. Application of capillary DNA
chromatography to detect AIDS virus (HIV-1) DNA in blood. J
Chromatogr 1990 Nov 30;533:87-96.
Buck BE, Malinin TI, Brown MD. Bone transplantation and human
immunodeficiency virus. An estimate of risk of acquired
immunodeficiency syndrome (AIDS). Clin Orthop 1989
Mar;(240):129-36.
Buckley JD, Pike MC, Mosley JW. Statistical approaches to
evaluating prognostic indices in HIV infection. The Transfusion
Safety Study Group [letter]. AIDS 1991 Nov;5(11):1398.
Burckhardt JJ, Zuercher-Krauskopf M, Senn M, Bachmann P. Six
years experience with follow-up of indeterminate anti-HIV western
blot in blood donors [abstract]. Int Conf AIDS 1992 Jul
19-24;8(2):C279 (abstract no. PoC 4206).
Busch M. HIV-1 p24 antigen screening of male blood donors in
localities with high HIV-1 antibody prevalence [abstract]. Int
Conf AIDS 1989 Jun 4-9;5:344 (abstract no. T.B.P.347).
Busch MP. Laboratory diagnosis of HIV infection. Transfus Med
Rev 1988 Dec;2(4):250-63.
Busch MP, Donegan E, Stuart M, Mosley JW. Donor HIV-1 p24
antigenaemia and course of infection in recipients Transfusion
Safety Study Group [letter]. Lancet 1990 Jun 2;335(8701):1342.
Busch M, Eble B, Ulrich P, El Amad Z, Perkins H, Vyas G.
Prospective evaluation of contemporary screened blood donors for
occult HIV infection [abstract]. Int Conf AIDS 1989 Jun 4-9;5:46
(abstract no. M.A.O. 10).
Busch MP, Eble BE, Babu G, Khayam-Bashi H, Heilbron D, Murphy EL,
Perkins HA, Vyas GN. Evaluation of contemporary screened blood
donors for HIV-1 infection using pooled cell culture and DNA
amplification techniques [abstract]. Transfusion 1991;31(8
Suppl):49s.
Busch MP, Eble BE, Khayam-Bashi H, Heilbron D, Murphy EL, Kwok S,
Sninsky J, Perkins HA, Vyas GN. Evaluation of screened blood
donations for human immunodeficiency virus type 1 infection by
culture and DNA amplification of pooled cells. N Engl J Med 1991
Jul 4;325(1):1-5.
Busch MP, el Amad Z, McHugh TM, Chien D, Polito AJ. Reliable
confirmation and quantitation of human immunodeficiency virus
type 1 antibody using a recombinant-antigen immunoblot assay.
Transfusion 1991 Feb;31(2):129-37.
Busch MP, Henrard DR, Hewlett IK, Mehaffey WF, Epstein JS, Allain
JP, Lee TH, Mosley JW. Poor sensitivity, specificity, and
reproducibility of detection of HIV-1 DNA in serum by polymerase
chain reaction. The Transfusion Safety Study Group. J Acquir
Immune Defic Syndr 1992;5(9):872-7.
Busch MP, Kleinman S, Calabro M, Laycock M, Thompson R,
Retrovirus. Evaluation of anti-HTLV supplemental testing in US
blood donors [abstract]. Transfusion 1992;32(8 Suppl):57s.
Busch MP, Laycock M, Kleinman SH, Wages JW Jr, Calabro M, Kaplan
JE, Khabbaz RF, Hollingsworth CG. Accuracy of supplementary
serologic testing for human T-lymphotropic virus types I and II
in US blood donors. Retrovirus Epidemiology Donor Study. Blood
1994 Feb 15;83(4):1143-8.
Busch MP, Perkins HA, Holland PV, Doll LS, Petersen L.
Questionable efficacy of confidential unit exclusion [letter].
Transfusion 1990 Sep;30(7):668-9. Comment on: Transfusion 1989
Nov-Dec;29(9):823-6. Comment in: Transfusion 1991 Mar-
Apr;31(3):286-7.
Busch MP, Petersen L, Schable C, Perkins H. Monitoring blood
donors for HIV-2 infection by testing anti-HIV-1 reactive sera.
Transfusion 1990 Feb;30(2):184-7.
Busch MP, Rajagopalan MS, Gantz DM, Fu S, Steimer KS, Vyas GN.
In situ hybridization and immunocytochemistry for improved
assessment of human immunodeficiency virus cultures. Am J Clin
Pathol 1987 Dec;88(6):673-80.
Busch MP, Taylor PE, Lenes BA, Kleinman SH, Stuart M, Stevens CE,
Tomasulo PA, Allain JP, Hollingsworth CG, Mosley JW. Screening
of selected male blood donors for p24 antigen of human
immunodeficiency virus type 1. The Transfusion Safety Study
Group. N Engl J Med 1990 Nov 8;323(19):1308-12. Comment in: N
Engl J Med 1991 Oct 17;325(16):1174-5.
Busch MP, Valinski J, Paglieroni T, Prince H, Mosley JW, et al.
Prevalence and significance of idiopathic CD4-Positive T-
Lymphocytopenia ICL in US voluntary blood donors [abstract]. Int
Conf AIDS 1993 Jun 6-11;9(1):92 (abstract no. WS-C11-1).
Busch MP, Valinsky JE, Paglieroni T, Prince HE, Crutcher GJ,
Gjerset GF, Operskalski EA, Charlebois E, Bianco C, Holland PV,
et al. Screening of blood donors for idiopathic CD4+ T-
lymphocytopenia. Transfusion 1994 Mar;34(3):192-7.
Busch MP, Young MJ, Samson SM, Mosley JW, Ward JW, Perkins HA.
Risk of human immunodeficiency virus (HIV) transmission by blood
transfusions before the implementation of HIV-1 antibody
screening. The Transfusion Safety Study Group. Transfusion 1991
Jan;31(1):4-11.
Calender A, Gessain A, Essex M, de The G. Seroepidemiology of
human T-cell leukemia virus in the French West Indies: antibodies
in blood donors and patients with lymphoproliferative diseases
who do not have AIDS. Ann N Y Acad Sci 1984;437:175-6.
Calman AF, Busch MP, Vyas GN, McHugh TM, Stites DP, Peterlin BM.
Transcription and replication of human immunodeficiency virus-1
in B lymphocytes in vitro. AIDS 1988 Jun;2(3):185-93.
Cantani A. [Acquired immunodeficiency syndrome (AIDS): the child
and the mother]. Allerg Immunol (Paris) 1990 Dec;22(10):419-24.
(Fre).
Carlson JR, Bryant ML, Hinrichs SH, Yamamoto JK, Levy NB, Yee J,
Higgins J, Levine AM, Holland P, Gardner MB, et al. AIDS
serology testing in low- and high-risk groups. JAMA 1985 Jun
21;253(23):3405-8.
Carlson JR, Yee J, Hinrichs SH, Bryant ML, Gardner MB, Pedersen
NC. Comparison of indirect immunofluorescence and Western blot
for detection of anti-human immunodeficiency virus antibodies. J
Clin Microbiol 1987 Mar;25(3):494-7.
Carr R, Veitch SE, Edmond E, Peutherer JF, Prescott RJ, Steel CM,
Ludlam CA. Abnormalities of circulating lymphocyte subsets in
haemophiliacs in an AIDS-free population. Lancet 1984 Jun
30;1(8392):1431-4.
Carson JL, Russell LB, Taragin MI, Sonnenberg FA, Duff AE, Bauer
S. The risks of blood transfusion: the relative influence of
acquired immunodeficiency syndrome and non-A, non-B hepatitis.
Am J Med 1992 Jan;92(1):45-52. Comment in: Am J Med 1992
Sep;93(3):356-8 and Am J Med 1992 Nov;93(5):586.
Casabona J, Barba G, Segura A. [Preliminary results of the
analysis of donations carried out in Catalonia from 1985 to 1987
(letter)]. Med Clin (Barc) 1990 Jan 20;94(2):77. (Spa).
Casey JM, Kim Y, Andersen PR, Watson KF, Fox JL, Devare SG.
Human T-cell lymphotropic virus type III: immunologic
characterization and primary structure analysis of the major
internal protein, p24. J Virol 1985 Aug;55(2):417-23.
Caspari G, Gerlich WH. [HIV-p24 antigen test in blood donors:
yes or no?]. Med Klin 1994 Jan 15;89(1):25-32, 47. Comment in:
Med Klin 1994 Jan 15;89(1):41. (Ger).
Castro O, Saxinger C, Barnes S, Alexander S, Flagg R, Frederick
W. Prevalence of antibodies to human immunodeficiency virus and
to human T cell leukemia virus type I in transfused sickle cell
disease patients. J Infect Dis 1990 Sep;162(3):743-5.
Ceuppens JL, Vermylen J, Colaert J, Desmyter J, Gautama K,
Stevens E, The AL, Vanham G, Vermylen C, Verstraete M.
Immunological alterations in haemophiliacs treated with
lyophilized Factor VIII cryoprecipitate from volunteer donors.
Thromb Haemost 1984 Apr 30;51(2):207-11.
Chamberland ME, Castro KG, Haverkos HW, Miller BI, Thomas PA,
Reiss R, Walker J, Spira TJ, Jaffe HW, Curran JW. Acquired
immunodeficiency syndrome in the United States: an analysis of
cases outside high-incidence groups. Ann Intern Med 1984
Nov;101(5):617-23.
Chamberland ME, Petersen LR, Munn VP, White CR, Johnson ES, Busch
MP, Grindon AJ, Kamel H, Ness PM, Shafer AW, et al. Human
immunodeficiency virus infection among health care workers who
donate blood. Ann Intern Med 1994 Aug 15;121(4):269-73.
Cheingsong-Popov R, Weiss RA, Dalgleish A, Tedder RS, Shanson DC,
Jeffries DJ, Ferns RB, Briggs EM, Weller IV, Mitton S, et al.
Prevalence of antibody to human T-lymphotropic virus type III in
AIDS and AIDS-risk patients in Britain. Lancet 1984 Sep
1;2(8401):477-80.
Chen ISY, Rosenblatt JD, Black AC, Arrigo SJ, Green PL. HTLV-II
prevalence and regulation of gene expression [abstract]. AIDS
Res Hum Retroviruses 1990;6(1):134-5.
Chiavetta JA, Nusbacher J, Wall A. Donor self-exclusion patterns
and human immunodeficiency virus antibody test results over a
twelve-month period. Transfusion 1989 Jan;29(1):81-3.
Chiodi F, Biberfeld G, Parks E, Norrby E, Mufson M. Screening of
African sera stored for more than 17 years for HIV antibodies by
site-directed serology. Eur J Epidemiol 1989 Mar;5(1):42-6.
Chitwood DD, Page JB, Comerford M, Inciardi JA, McCoy CB, Trapido
E, Lai SH. The donation and sale of blood by intravenous drug
users. Am J Public Health 1991 May;81(5):631-3.
Chorba TL, Jason JM, Ramsey RB, Lechner K, Pabinger-Fasching I,
Kalyanaraman VS, McDougal JS, Cabradilla CD, Tregillus LC,
Lawrence DN, et al. HTLV-I antibody status in hemophilia
patients treated with factor concentrates prepared from U.S.
plasma sources and in hemophilia patients with AIDS. Thromb
Haemost 1985 Apr 22;53(2):180-2.
Church JA, Isaacs H. Transfusion-associated acquired immune
deficiency syndrome in infants. J Pediatr 1984 Nov;105(5):731-7.
Cleary PD, Rogers TF, Singer E, Avorn J, van Devanter N, Perry S,
Pindyck J. Health education about AIDS among seropositive blood
donors. Health Educ Q 1986 Winter;13(4):317-29.
Cleary PD, Singer E, Rogers TF, Avorn J, Van Devanter N, Soumerai
S, Perry S, Pindyck J. Sociodemographic and behavioral
characteristics of HIV antibody-positive blood donors. Am J
Public Health 1988 Aug;78(8):953-7.
Cleary PD, Van Devanter N, Rogers TF, Singer E, Avorn J, Pindyck
J. Trends in sociodemographic and behavioral characteristics of
HIV antibody-positive blood donors. AIDS Educ Prev 1991
Spring;3(1):60-71.
Cleary PD, Van Devanter N, Rogers TF, Singer E, Shipton-Levy R,
Steilen M, Stuart A, Avorn J, Pindyck J. Depressive symptoms in
blood donors notified of HIV infection. Am J Public Health 1993
Apr;83(4):534-9.
Clerici M, Berzofsky JA, Shearer GM, Giorgi JV, Tacket C. HIV-1
from a seronegative transplant donor [letter]. N Engl J Med 1992
Aug 20;327(8):564-5. Comment on: N Engl J Med 1992 Mar
12;326(11):726-32.
Cohen ND, Munoz A, Reitz BA, Ness PK, Frazier OH, Yawn DH, Lee H,
Blattner W, Donahue JG, Nelson KE, et al. Transmission of
retroviruses by transfusion of screened blood in patients
undergoing cardiac surgery. N Engl J Med 1989 May
4;320(18):1172-6. Comment in: N Engl J Med 1989 Nov
9;321(19):1338-9.
Coll J, Yazbeck H, Gutierrez J. [Anticardiolipin antibodies in
patients infected with the human immunodeficiency virus type 1
(letter)]. Med Clin (Barc) 1993 Mar 6;100(9):357-8. (Spa).
Colman N. Introduction: closing the window on AIDS. Transfus
Med Rev 1989 Jan;3(1 Suppl 1):1-3.
Conley LJ, Holmberg SD. Transmission of AIDS from blood screened
negative for antibody to the human immunodeficiency virus
[letter]. N Engl J Med 1992 May 28;326(22):1499-500.
Conri C, Mestre C, Constans J, Vital C. [Periarteritis nodosa-
type vasculitis and infection with human immunodeficiency virus].
Rev Med Interne 1991 Jan-Feb;12(1):47-51. (Fre).
Consensus conference. Perioperative red blood cell transfusion.
JAMA 1988 Nov 11;260(18):2700-3.
The constitutional rights of AIDS carriers. Harvard Law Rev 1986
Apr;99(6):1274-92.
Conte JE. Infection with human immunodeficiency virus in the
hospital: epidemiology, infection control, and biosafety
considerations. Ann Intern Med 1986 Nov;105(5):730-6.
Contreras M, Barbara J. Screening for HIV p24 antigen [letter].
Lancet 1992 Feb 15;339(8790):438-9. Comment on: Lancet 1992 Jan
11;339(8785):130-1.
Contreras M, Hewitt PE, Barbara JA, Mochnaty PZ. Blood donors at
high risk of transmitting the acquired immune deficiency
syndrome. Br Med J (Clin Res Ed) 1985 Mar 9;290(6470):749-50.
Courouce AM. [HIV seropositivity in blood donors and estimation
of the residual risk of transfusion (abstract)]. Int Conf AIDS
1989 Jun 4-9;5:83. (Fre).
Courouce AM. [HIV seropositivity in blood donors from 1990 to
1992: prevalence, estimation of residual risk of transfusion-
related infections and epidemiology]. Rev Fr Transfus Hemobiol
1993 Jul;36(4):327-37. (Fre).
Courouce AM. [Type C viral hepatitis]. Rev Fr Transfus Hemobiol
1990 Mar;33(2):81-95. (Fre).
Courouce AM, Barin F, Maniez M, Janot C, Noel L, Elghouzzi MH.
Effectiveness of assays for antibodies to HIV and p24 antigen to
detect very recent HIV infections in blood donors. The Retrovirus
Study Group of the French Society of Blood Transfusion [letter].
AIDS 1992 Dec;6(12):1548-50.
Courouce AM, Baudelot J, Elghouzzi MH, Gueguen M, Janot C,
Lemaire JM, Maniez M, Mesnier F, Noel L, North ML, et al.
[Prevalence and epidemiologic features of subjects found to be
infected with HIV when donating blood. CTS of the Retrovirus
Study Group of the Societe Nationale de Transfusion Sanguine].
Rev Fr Transfus Hemobiol 1990 Dec;33(6):431-8. (Fre).
Cumming PD, Wallace EL, Schorr JB, Dodd RY. Exposure of patients
to human immunodeficiency virus through the transfusion of blood
components that test antibody-negative. N Engl J Med 1989 Oct
5;321(14):941-6. Comment in: N Engl J Med 1990 Mar
22;322(12):850-1.
Curran WJ. AIDS research and the window of opportunity. N Eng J
Med 1985 Apr 4;312(14):903-4.
Curran JW, Barker LF. The acquired immunodeficiency syndrome
associated with transfusions: the evolving perspective. Ann
Intern Med 1984 Feb;100(2):298-300.
Curran JW, Lawrence DN, Jaffe H, Kaplan JE, Zyla LD, Chamberland
M, Weinstein R, Lui KJ, Schonberger LB, Spira TJ, et al.
Acquired immunodeficiency syndrome (AIDS) associated with
transfusions. N Engl J Med 1984 Jan 12;310(2):69-75.
Dai ZC. AIDS prevention and control in China. Chin Med J (Engl)
1991 Oct;104(10):795-8.
Das PC, de Vries AH, McShine RL, Smit Sibinga CT. HIV antigen
tests on selected blood donors [abstract]. Int Conf AIDS 1990
Jun 20-23;6(1):274 (abstract no. Th.C.598).
Das PC, de Vries AH, McShine RL, Smit Sibinga CT. HIV antigen
tests among new blood donors [abstract]. Int Conf AIDS 1989 Jun
4-9;5:346 (abstract no. T.B.P. 354).
Daul CB, deShazo RD, Andes WA. Human immunodeficiency virus
infection in hemophiliac patients. A three-year prospective
evaluation. Am J Med 1988 May;84(5):801-9.
de Juan Martin F, Gomez Barrena V, Garcia Vera C, Gresa Munoz M,
Arcauz Eguren P, Omenaca Teres M, Martin Moradillo M. [Visceral
leishmaniasis revealing post-transfusional HIV infection]. An
Esp Pediatr 1991 Feb;34(2):158-60. (Spa).
de la Cruz CA, de Diego R, Canal MI, Cabrerizo P, Tisner M, Navia
J. [Anesthesiologic implications of human immunodeficiency virus
(HIV) infection]. Rev Esp Anestesiol Reanim 1990 Mar-
Apr;37(2):75-80. (Spa).
de Stasio G. [Transfusion risks and alternatives to
transfusion]. Recenti Prog Med 1992 Jun;83(6):321-9. (Ita).
de Vries HR. [Doctor's delay in HIV infection caused by blood
transfusion (letter)]. Ned Tijdschr Geneeskd 1992 Oct
3;136(40):1989. (Dut).
Debat P, Houndo L, Arulnaden JL, Lemonnier MP, Bismuth A.
[Detection of HIV in donated blood]. Rev Fr Transfus Hemobiol
1992 Jan;35(1):11-2. (Fre).
Dekaban G, Inwood M, Waters D, Drouin J, Teitel J. Absence of
human T-lymphotropic virus types I and II infection in an Ontario
hemophilia population. Transfusion 1992 Jul-Aug;32(6):513-6.
Delaporte E, Peeters M, Bardy JL, Ville Y, Placca L, Bedjabaga I,
Larouze B, Piot P. Blood transfusion as a major risk factor for
HTLV-I infection among hospitalized children in Gabon (Equatorial
Africa). J Acquir Immune Defic Syndr 1993 Apr;6(4):424-8.
DePalma L, Luban NL. Transmission of human T-lymphotrophic virus
type I infection to a neonatal infant by transfusion of washed
and irradiated red cells. Transfusion 1993 Jul;33(7):582-4.
Desfemmes T, Chouaid C, Febvre M, Housset B, Lebeau B.
[Geriatric AIDS (6 years after pneumonectomy). Apropos of a
case]. Rev Pneumol Clin 1991;47(4):192-3. (Fre).
Desposito F, McSherry GD, Oleske JM. Blood product acquired HIV
infection in children. Pediatr Ann 1988 May;17(5):341-5.
Di Nola F. [AIDS in Italy]. Minerva Chir 1991 Oct
31;46(20):1150-1. (Ita).
Di Nola F. [AIDS in transplantation]. Minerva Urol Nefrol 1992
Jul-Sep;44(3):230-1. (Ita).
Dickens BM. Legal rights and duties in the AIDS epidemic.
Science 1988 Feb 5;239(4840):580-6.
Dietrich SL. The epidemiology of HIV infection in hemophiliacs.
Prog Clin Biol Res 1990;324:79-86.
Dietrich SL, Mosley JW, Lusher JM, Hilgartner MW, Operskalski EA,
Habel L, Aledort LM, Gjerset GF, Koerper MA, Lewis BH, et al.
Transmission of human immunodeficiency virus type 1 by dry-heated
clotting factor concentrates. Transfusion Safety Study Group.
Vox Sang 1990;59(3):129-35.
Dobec M, Jung M, Zupancic-Salek S, Burek V, Mihaljevic I,
Grgicevic D. [The combined immunoenzyme test: anti-HIV-1 and -2
and anti-HTLV-1 in the detection of donors with retrovirus
infections]. Lijec Vjesn 1993 May-Jun;115(5-6):142-5. (Scr).
Dock NL, Kleinman SH, Rayfield MA, Schable CA, Williams AE, Dodd
RY. Human immunodeficiency virus infection and indeterminate
western blot patterns. Prospective studies in a low prevalence
population. Arch Intern Med 1991 Mar;151(3):525-30.
Dock NL, Lamberson HV Jr, O'Brien TA, Tribe DE, Alexander SS,
Poiesz BJ. Evaluation of atypical human immunodeficiency virus
immunoblot reactivity in blood donors. Transfusion 1988 Sep-
Oct;28(5):412-8.
Dodd RY, Fang CT. The western immunoblot procedure for HIV
antibodies and its interpretation. Arch Pathol Lab Med 1990
Mar;114(3):240-5.
Dodd RY, Houlihan K, Lamberson HV. The specificity of enzyme
immunoassays for antibodies to human immunodeficiency virus:
impact on record and donor management [letter]. Transfusion 1993
Aug;33(8):693.
Doll L. Homosexually and nonhomosexually identified male blood
donors who have sex with men a behavioral comparison [abstract].
Int Conf AIDS 1990 Jun 20-23;6(1):146 (abstract no. Th.D.49).
Doll LS, Petersen LR, White CR, Ward JW. Human immunodeficiency
virus type 1-infected blood donors: behavioral characteristics
and reasons for donation. The HIV Blood Donor Study Group.
Transfusion 1991 Oct;31(8):704-9.
Domok I, Illes B, Foldes I, Kulcsar G, Fust G, Vass A, Horvath A,
Varnai F, Endroczi E. [The position of the AIDS Committee of the
Ministry of Social and Health Services on the publication:
Controversies Concerning AIDS, published in Medicus Universalis,
No.6, 1989]. Orv Hetil 1990 Aug 12;131(32):1765-7. (Hun).
Donahue JG, Nelson KE, Munoz A, McAllister HA, Yawn DH, Ness PM,
Cohen ND. Transmission of HIV by transfusion of screened blood
[letter]. N Engl J Med 1990 Dec 13;323(24):1709.
Donegan E, Busch MP, Galleshaw JA, Shaw GM, Mosley JW.
Transfusion of blood components from a donor with human T-
lymphotropic virus type II (HTLV-II) infection. The Transfusion
Safety Study Group. Ann Intern Med 1990 Oct 1;113(7):555-6.
Donegan E, Johnson D, Remedios V, Cohen S. Mass notification of
transfusion recipients at risk for HIV infection [letter]. JAMA
1988 Aug 19;260(7):922-3.
Donegan E, Lee H, Operskalski EA, Shaw GM, Kleinman SH, Busch MP,
Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG, et al.
Transfusion transmission of retroviruses: human T-lymphotropic
virus types I and II compared with human immunodeficiency virus
type 1. Transfusion 1994 Jun;34(6):478-83.
Donegan E, Lenes BA, Tomasulo PA, Mosley JW, Mosely JW/[corrected
to Mosley JW]. Transmission of HIV-1 by component type and
duration of shelf storage before transfusion [letter].
Transfusion 1990 Nov-Dec;30(9):851-2. Published erratum appears
in Transfusion 1991 Mar-Apr;31(3):287.
Donegan E, Pell P, Lee H, Shaw GM, Mosley JW. Transmission of
human T-lymphotropic virus type I by blood components from a
donor lacking anti-p24: a case report. The Transfusion Safety
Study Group. Transfusion 1992 Jan;32(1):68-71.
Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL,
Faucett C, Fletcher MA, Kleinman SH, Operskalski EA, et al.
Infection with human immunodeficiency virus type 1 (HIV-1) among
recipients of antibody-positive blood donations. Ann Intern Med
1990 Nov 15;113(10):733-9. Comment in: Ann Intern Med 1990
Nov;113(10):729-30.
Douglas D, Harper M, Ness P, Polk F. HIV antibody and concurrent
serologic markers in male blood donors who deny risk [abstract].
Transfusion (Phila) 1987;27(6):549.
Dudok de Wit C. [HIV-positive blood donors, 1985-1993]. Ned
Tijdschr Geneeskd 1994 May 28;138(22):1135. (Dut).
Dufoort G, Courouce AM, Ancelle-Park R, Bletry O. No clinical
signs 14 years after HIV-2 transmission via blood transfusion
[letter]. Lancet 1988 Aug 27;2(8609):510.
Dupont E, Lambermont M. [Prevention of risks related to blood
transfusions]. Rev Med Brux 1993 Mar;14(3):59-62. (Fre).
Eberle J, Gathof B, Backer U, Gossrau E, Stute R, Baumgarten K,
Bergmann H, Reissigl H, Gurtler L, Deinhardt P. p24 HIV antigen
screening of blood donors [abstract]. Int Conf AIDS 1989 Jun
4-9;5:246 (abstract no. M.B.P.148).
Eble B, Busch M, Hurt M, Nason M, Garner J, Guiltinan A, Vyas G,
Khayam-Bashi H. Resolution of western blot-indeterminate and
high risk seronegative blood donors by PCR [abstract]. Int Conf
AIDS 1990 Jun 20-23;6(1):136 (abstract no. Th.A.12).
Eble BE, Busch MP, Guiltinan AM, Khayam-Bashi H, Murphy EL.
Determination of human T lymphotropic virus type by polymerase
chain reaction and correlation with risk factors in northern
California blood donors. J Infect Dis 1993 Apr;167(4):954-7.
Published erratum appears in J Infect Dis 1993 Jul;168(1):262.
Eble BE, Busch MP, Khayam-Bashi H, Nason MA, Samson S, Vyas GN.
Resolution of infection status of human immunodeficiency virus
(HIV)-seroindeterminate donors and high-risk seronegative
individuals with polymerase chain reaction and virus culture:
absence of persistent silent HIV type 1 infection in a high-
prevalence area. Transfusion 1992 Jul-Aug;32(6):503-8. Comment
in: Transfusion 1992 Jul-Aug;32(6):497-9.
Eggers HJ. [Value of the HIV-p24 antigen test in blood banks
(editorial)]. Med Klin 1994 Jan 15;89(1):41. Comment on: Med
Klin 1994 Jan 15;89(1):25-32, 47. (Ger).
Ehmke W, Bielefeld, Haike HJ. [Administration of an HIV
contaminated blood unit and hospital liability].
Versicherungsmedizin 1992 Jun 1;44(3):76-80. (Ger).
Eichberg JW, Alter HJ, Dreesman GR. Longitudinal study of HTLV-
III-infected chimpanzees by lymphocyte subpopulation analysis. J
Med Primatol 1985;14(6):317-26.
Eichberg JW, Zarling JM, Alter HJ, Levy JA, Berman PW, Gregory T,
Lasky LA, McClure J, Cobb KE, Moran PA, et al. T-cell responses
to human immunodeficiency virus (HIV) and its recombinant
antigens in HIV-infected chimpanzees. J Virol 1987
Dec;61(12):3804-8.
Eiseman B, Schrotter G. [Perioperative blood transfusions.
Changed indications and new alternatives]. Zentralbl Chir
1990;115(4):193-9. (Ger).
Eisenstaedt RS, Getzen TE. Screening blood donors for human
immunodeficiency virus antibody: cost-benefit analysis. Am J
Public Health 1988 Apr;78(4):450-4.
Eklund J, Jorgensen J, Hogman C, Jensson O, Kornstad L.
[Recommendations from the 12th Scandinavian meeting on
transfusion medicine]. Nord Med 1990;105(4):119-20. (Dan).
Epstein JS. Sensitivity and consistency of screening tests for
antibodies to human immunodeficiency virus type 1 [editorial].
Transfusion 1991 Jun;31(5):388-9.
Epstein JS, Fricke WA. Current safety of clotting factor
concentrates. Arch Pathol Lab Med 1990 Mar;114(3):335-40.
Comment in: Arch Pathol Lab Med 1990 Dec;114(12):1188-9.
Estermann J, Sulliger JM, Skarabis H. [Epidemiology of HIV
infections in Switzerland and the German Federal Republic--
contribution of official surveillance systems, of anonymous
testing and of blood donor screening]. Gesundheitswesen 1992
Mar;54(3):122-6. (Ger).
Evatt BL, Chorba TL. Acquired immunodeficiency syndrome (AIDS)
in hemophilia. Clin Lab Med 1984 Jun;4(2):333-44.
Evatt BL, Gomperts ED, McDougal JS, Ramsey RB. Coincidental
appearance of LAV/HTLV-III antibodies in hemophiliacs and the
onset of the AIDS epidemic. N Engl J Med 1985 Feb
21;312(8):483-6.
Evatt BL, Ramsey RB, Lawrence DN, Zyla LD, Curran JW. The
acquired immunodeficiency syndrome in patients with hemophilia.
Ann Intern Med 1984 Apr;100(4):499-504.
Evatt BL, Stein SF, Francis DP, Lawrence DN, McLane MF, McDougal
JS, Lee TH, Spira TJ, Cabradilla C, Mullens JI, Essex M.
Antibodies to human T cell leukaemia virus-associated membrane
antigens in haemophiliacs: evidence for infection before 1980.
Lancet 1983 Sep 24;2(8352):698-700.
Eyster ME, Alter HJ, Aledort LM, Quan S, Hatzakis A, Goedert JJ.
Heterosexual co-transmission of hepatitis C virus (HCV) and human
immunodeficiency virus (HIV). Ann Intern Med 1991 Nov
15;115(10):764-8.
Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert
JJ. Natural history of hepatitis C virus infection in
multitransfused hemophiliacs: effect of coinfection with human
immunodeficiency virus. The Multicenter Hemophilia Cohort Study.
J Acquir Immune Defic Syndr 1993 Jun;6(6):602-10.
Fabre G, Joussemet M, Vincent M. [Epidemiologic study of HIV
serology among blood donors in the north-eastern region of
France]. Rev Fr Transfus Hemobiol 1990 Jun;33(3):223-5. (Fre).
Falchek MM, Alter HJ. Transmission of HTLV-I by blood
transfusion in cardiac surgery patients [abstract]. Transfusion
(Phila) 1988;28(6 Suppl):22s.
Farzadegan H, Vlahov D, Solomon L, Munoz A, Astemborski J, Taylor
E, Burnley A, Nelson KE. Detection of human immunodeficiency
virus type 1 infection by polymerase chain reaction in a cohort
of seronegative intravenous drug users. J Infect Dis 1993
Aug;168(2):327-31.
Feorino PM, Jaffe HW, Palmer E, Peterman TA, Francis DP,
Kalyanaraman VS, Weinstein RA, Stoneburner RL, Alexander WJ,
Raevsky C, et al. Transfusion-associated acquired
immunodeficiency syndrome. Evidence for persistent infection in
blood donors. N Engl J Med 1985 May 16;312(20):1293-6.
Feorino PM, Kalyanaraman VS, Haverkos HW, Cabradilla CD, Warfield
DT, Jaffe HW, Harrison AK, Gottlieb MS, Goldfinger D, Chermann
JC, et al. Lymphadenopathy associated virus infection of a blood
donor--recipient pair with acquired immunodeficiency syndrome.
Science 1984 Jul 6;225(4657):69-72.
Fiedler H. Can anti-HBc testing decrease the residual risk of
transfusion-related HIV transmission? [letter]. Vox Sang
1991;61(2):144-5.
Fiedler H. [HIV: how big is the residual risk? (letter)]. Dtsch
Med Wochenschr 1993 Dec 17;118(50):1867. (Ger).
Fincher RM, de Silva M, Lobel S, Spencer M. AIDS-related complex
in a heterosexual man seven weeks after a transfusion [letter].
N Engl J Med 1985 Nov 7;313(19):1226-7.
Fiore JR, Angarano G, Fico C, Di Stefano M, Fracasso C, Pastore
G. [Isolation of human immunodeficiency virus (HIV) from whole
blood]. Boll Soc Ital Biol Sper 1991 May;67(5):535-42. (Ita).
Fletcher MA, Azen SP, Adelsberg B, Gjerset G, Hassett J, Kaplan
J, Niland JC, Odom-Maryon T, Parker JW, Stites DP, et al.
Immunophenotyping in a multicenter study: the Transfusion Safety
Study experience. Clin Immunol Immunopathol 1989
Jul;52(1):38-47.
Fletcher MA, Gjerset GF, Hassett J, Donegan E, Parker JW, Mosley
JW. Lymphocyte immunophenotypes among anti-HTLV-I/II-positive
blood donors and recipients. The Transfusion Safety Study Group.
J Acquir Immune Defic Syndr 1991;4(6):628-32.
Fletcher MA, Mosley JW, Hassett J, Gjerset GF, Kaplan J, Parker
JW, Donegan E, Lusher JM, Lee H. Effect of age on human
immunodeficiency virus type 1-induced changes in lymphocyte
populations among persons with congenital clotting disorders.
Transfusion Safety Study Group. Blood 1992 Aug 1;80(3):831-40.
Flores-Castaneda MS, Salinas-Carmona MC, Yanez-Rodriguez A.
[Immunoelectroblotting in Mexican subjects at high risk for
infection with human immunodeficiency virus (HIV)]. Rev Invest
Clin 1991 Jul-Sep;43(3):229-33. (Spa).
Food and Drug Administration (US). General biological products
standards, additional standards for human blood and blood
products; test for antibody to human immunodeficiency virus
(HIV); final rule. Fed Reg 1988 Jan 5;53(2):111-7.
Fournel JJ. [Second symposium on transfusion security].
Transfus Clin Biol 1994;1(3):177-9. (Fre).
Fournel JJ, Baudin C. [Blood transfusions: improved safety
(interview of Dr. J.J. Fournel by Chantal Baudin)]. Chir Dent Fr
1991 Apr 11;61(560):43-8. (Fre).
Francis DP, Curran JW, Essex M. Epidemic acquired immune
deficiency syndrome: epidemiologic evidence for a transmissible
agent. J Natl Cancer Inst 1983 Jul;71(1):1-4.
Frenzel H, Lefevre H. [Infection hazard due to blood or blood
components (letter)]. Dtsch Med Wochenschr 1993 Sep
17;118(37):1341; discussion 1344. (Ger).
Frey L, Pacheco A, Messmer K. [Preoperative isovolemic
hemodilution]. Beitr Infusionther 1993;29:40-50. (Ger).
Friedland GH, Klein RS. Transmission of the human
immunodeficiency virus. N Engl J Med 1987 Oct
29;317(18):1125-35.
Fuchs D, Hausen A, Reibnegger G, Schoenitzer D, Werner ER,
Dierich MP, Wachter H. HIV vaccination and blood transfusion
[letter]. Nature 1987 Dec 24-31;330(6150):702-3.
Fuchs D, Wachter H, Schonitzer D. [Neopterin and blood
transfusion (letter)]. Dtsch Med Wochenschr 1992 Oct
9;117(41):1578-9. (Ger).
Fultz PN, McClure HM, Swenson RB, McGrath CR, Brodie A, Getchell
JP, Jensen FC, Anderson DC, Broderson JR, Francis DP. Persistent
infection of chimpanzees with human T-lymphotropic virus type
III/lymphadenopathy-associated virus: a potential model for
acquired immunodeficiency syndrome. J Virol 1986
Apr;58(1):116-24.
Gadol N, Crutcher GJ, Busch MP. Detection of intracellular HIV
in lymphocytes by flow cytometry. Cytometry 1994 Apr
1;15(4):359-70.
Gamba G. [Immunologic changes in polytransfused hemophiliacs].
Haematologica 1991 Jun;76 Suppl 3:420-3. (Ita).
Garcia-Martos P, Bascunana A, Benjumeda M, Guerrero F, Marin P,
de la Rubia F. [Pneumonia caused by Rhodococcus equi in a
patient with AIDS (letter)]. Enferm Infecc Microbiol Clin 1991
Dec;9(10):664. (Spa).
Garovoy MR, Engleman EG. Immune mechanisms in transfusion.
Transfus Med Rev 1988 Dec;2(4):275-7.
Gascon P, Zoumbos NC, Young NS. Immunologic abnormalities in
patients receiving multiple blood transfusions. Ann Intern Med
1984 Feb;100(2):173-7.
Gaynor S, Kessler D, Berge P, Andrews S, DelValle C. Risk
factors for HIV among New York blood donors in 1988 [abstract].
Int Conf AIDS 1989 Jun 4-9;5:245 (abstract no. M.B.P.141).
Gelles GM. Costs and benefits of HIV-1 antibody testing of
donated blood. J Policy Anal Manage 1993 Summer;12(3):512-31.
Genesca J, Shih JW, Esteban JI, Alter HJ. Comparison of four
different antigen-capture assays for the detection of human
immunodeficiency virus antigen (HIV-Ag). J Acquir Immune Defic
Syndr 1989;2(2):170-77.
Genesca J, Shih JW, Jett BW, Hewlett IK, Epstein JS, Alter HJ.
What do western blot indeterminate patterns for human
immunodeficiency virus mean in EIA-negative blood donors? Lancet
1989 Oct 28;2(8670):1023-5. Comment in: Lancet 1989 Dec
2;2(8675):1330-1 and Lancet 1990 Feb 3;335(8684):292-3.
Genesca J, Wang RY, Alter HJ, Shih JW. Clinical correlation and
genetic polymorphism of the human immunodeficiency virus proviral
DNA obtained after polymerase chain reaction amplification. J
Infect Dis 1990 Nov;162(5):1025-30.
George JR, Rayfield MA, Phillips S, Heyward WL, Krebs JW,
Odehouri K, Soudre R, De Cock KM, Schochetman G. Efficacies of
US Food and Drug Administration-licensed HIV-1-screening enzyme
immunoassays for detecting antibodies to HIV-2. AIDS 1990
Apr;4(4):321-6.
Gibbons J, Cory JM, Hewlett IK, Epstein JS, Eyster ME. Silent
infections with human immunodeficiency virus type 1 are highly
unlikely in multitransfused seronegative hemophiliacs. Blood
1990 Nov 15;76(10):1924-6. Comment in: Blood 1991 Oct
1;78(7):1893-4.
Gilcher RO, Chandler LK, Belcher LO, Smith JW. A comparison of
serologic characteristics in HIV antibody positive vs. HIV
antibody negative volunteer blood donors [abstract]. Int Conf
AIDS 1989 Jun 4-9;5:920 (abstract no. E.709).
Gilcher RO, Swanda S, Belcher L, Swenson S. HTLV-I a transfusion
medicine problem [abstract]. Transfusion (Phila) 1988;28(6
Suppl):21s.
Gimble JG, Friedman LI. Effects of oral donor questioning about
high-risk behaviors for human immunodeficiency virus infection.
Transfusion 1992 Jun;32(5):446-9.
Girard A. [Leukocyte depletion of blood products and post-
transfusion infections]. Rev Fr Transfus Hemobiol 1993
Jun;36(3):265-79. (Fre).
Girard M, Macron M, Senechal C, Fournier B, Bombail D. Detection
of HIV antigen in blood donors [abstract]. Int Conf AIDS 1993
Jun 6-11;9(2):739 (abstract no. PO-C21-3134).
Gjerset GF, Mosley JW. Safety of factor VIII [letter]. Ann
Intern Med 1991 Jan 15;114(2):171. Comment on: Ann Intern Med
1990 Jul 1;113(1):27-32.
Gjerset GF, Pike MC, Mosley JW, Hassett J, Fletcher MA, Donegan
E, Parker JW, Counts RB, Zhou Y, Kasper CK, et al. Effect of
low- and intermediate-purity clotting factor therapy on
progression of human immunodeficiency virus infection in
congenital clotting disorders. Transfusion Safety Study Group.
Blood 1994 Sep 1;84(5):1666-71.
Gladysz A, Machaj A, Simon K, Gruszecka H, Molin I, Lukowiak J.
[Clinical characteristics of patients with AIDS treated at the
Infectious Disease Clinic, Medical Academy, in Wroclaw during the
years 1989-1990]. Przegl Epidemiol 1991;45(4):365-8. (Pol).
Global programme on AIDS. Wkly Epidemiol Rec 1993 Oct
29;68(44):321-3. (Eng, Fre).
Global programme on AIDS. A study on the effect of blood
transfusion on survival among children in a Kenyan hospital.
Wkly Epidemiol Rec 1994 Mar 11;69(10):69-71. (Eng, Fre).
Global programme on AIDS and global blood safety initiative.
Recommendations for testing for HIV antibody on serum pools.
Wkly Epidemiol Rec 1991 Nov 1;66(44):326-7. (Eng, Fre).
Gloskowska-Moraczewska Z, Seyfriedowa H. [Dubious results of
determining the presence of anti-HIV-1 antibodies in blood
donors]. Acta Haematol Pol 1991;22(1):120-6. (Pol).
Gluck D, Kubanek B. [Recent data on HIV epidemiology in
Germany]. Beitr Infusionther 1993;31:1-4. (Ger).
Gluck D, Kubanek B, Caspari G, Elbert G, Gathof B, Grassmann W,
Hesse R, Holzberger G, Koerner K, Richter K, et al. [HIV study
of the German Red Cross of West Germany 1985-1989:
prevalence/incidence and mode of infection, retrospective
studies]. Beitr Infusionther 1990;26:1-4. (Ger).
Gluck D, Kubanek B, Gaus W, Elbert G, Grassmann W, Hesse R,
Holzberger G, Koerner K, Mendner T, Peichl-Hoffmann G, et al.
[HIV study of German Red Cross blood banks in Germany and
Berlin]. Beitr Infusionther 1991;28:7-8. (Ger).
Gluck D, Kubanek B, Gaus W, Elbert G, Grassmann W, Hesse R,
Holzberger G, Koerner K, Peichl-Hoffmann G, Richter K. [Current
data on the prevalence and epidemiology of HIV from the HIV study
by the German Red Cross of West Germany]. Infusionstherapie 1990
Jun;17(3):160-2. Published erratum appears in Infusionstherapie
1990 Aug;17(4):230. (Ger).
Gneragbe T, Mutombo T. [Acquired immunodeficiency syndrome
(AIDS) in a rural milieu. Case of Dabou and its surroundings].
Med Trop (Mars) 1993 Jul-Sep;53(3):309-13. (Fre).
Gongora-Biachi RA, Gonzalez-Martinez P, Puerto IF, Alvarez-Moguel
R. [Prevalence of retrovirus (HIV-1 and HTLV-I) infection in
blood donors in the state of Yucutan, Mexico (letter)]. Sangre
(Barc) 1990 Dec;35(6):489-90. (Spa).
Gonzalez-Martinez P, Castro-Sansores C, Vivas-Rosel ML, Gongora-
Biachi RA. [Infection by human T-cell lymphotropic virus type
I/II in polytransfused patients in the state of Yucatan, Mexico].
Sangre (Barc) 1994 Feb;39(1):45-8. (Spa).
Goodnough LT. Erythropoietin as a pharmacologic alternative to
blood transfusion in the surgical patient. Transfus Med Rev 1990
Oct;4(4):288-96.
Goodnough LT, Shuck JM. Risks, options, and informed consent for
blood transfusion in elective surgery. Am J Surg 1990
Jun;159(6):602-9. Comment in: Am J Surg 1992 Mar;163(3):366-7.
Gostin L. Acquired immune deficiency syndrome: a review of
science, health policy, and law. In: Witt MD, editor. AIDS and
patient management: legal, ethical and social issues. Owings Mill
(MD): National Health Publishing; 1986. p. 3-24.
Gostin L, Curran WJ. AIDS screening, confidentiality, and the
duty to warn. Am J Pub Health 1987 Mar;77(3):361-5.
Gotz JM, Nielander AJ, Brouwers PJ, ten Napel CH. [Doctor's
delay in HIV infection caused by blood transfusion]. Ned
Tijdschr Geneeskd 1992 Aug 15;136(33):1611-3. (Dut).
Grandgeorge M, Pelloquin F. Inactivation of the human
immunodeficiency viruses (HIV-1 and HIV-2) during the
manufacturing of placental albumin and gammaglobulins.
Transfusion 1989 Sep;29(7):629-34.
Gras C, Gendron Y, Philippon G, Chungue E, Laudon F, Sirven D,
Renaud A, Lebras J, Cardines D, Prigent D, et al.
[Epidemiological surveillance of infection by the human
immunodeficiency virus (HIV) and of the acquired immunodeficiency
syndrome (AIDS) in French Polynesia in 1991]. Med Trop (Mars)
1992 Jan-Mar;52(1):51-6. (Fre).
Greatbatch W, Holmes W. Blood transfusion and AIDS in the USA.
J R Soc Health 1991 Aug;111(4):123-5.
Greve PA Jr. Medical, ethical, and legal issues associated with
HIV. J Intraven Nurs 1991 May-Jun;14(3 Suppl P):S30-5;
discussion S36-7.
Grindon AJ, Critchley SE, Ward JW. Risk of HIV infection in
recipients of untested blood from donors now anti-HIV-positive.
Transfusion 1988 Sep-Oct;28(5):419-21.
Groopman JE, Salahuddin SZ, Sarngadharan MG, Mullins JI, Sullivan
JL, Mulder C, O'Hara CJ, Cheeseman SH, Haverkos H, Forgacs P, et
al. Virologic studies in a case of transfusion-associated AIDS.
N Engl J Med 1984 Nov 29;311(22):1419-22.
Grunenberg R, Kruger J. [Screening for HIV-1 antibodies in
recipients of potentially HIV infected preserved blood]. Beitr
Infusionther 1990;26:12-4. (Ger).
Guillard A, Tirtaine C, Ouzan D, Follana R. [The medical
interview motivated by the discovery of markers of viral
hepatitis permits the identification, in blood donors, of
behavior at risk for HIV infection]. Rev Fr Transfus Hemobiol
1990 Jul;33(4):249-58. (Fre).
Gurtler L. [Viral safety of blood and blood products]. Fortschr
Med 1993 Nov 30;111(33):526-7. (Ger).
Gurtler L, Schramm W. [Infection risk caused by blood or blood
products (editorial)]. Dtsch Med Wochenschr 1993 Apr
8;118(14):520-2. (Ger).
Gurtler LG. [Current aspects of HIV infection]. Beitr
Infusionther 1991;28:1-6. (Ger).
Hamerschlak N. AIDS risk and prevention in transfusions. Nat
Immun Cell Growth Regul 1990;9(3):150-4.
Hamerschlak N, Pasternak J, Amato Neto V. [Current risk of AIDS
transmission by transfusion]. Rev Hosp Clin Fac Med Sao Paulo
1993 Jul-Aug;48(4):183-5. (Por).
Hanfland P. [Synopsis of the newest regulations for hemotherapy:
consequences for physicians and hospital insurance (editorial)].
Infusionsther Transfusionsmed 1993 Jun;20(3):70-4. (Ger).
Hardy AM. AIDS knowledge and attitudes for October-December
1990. Provisional data from the National Health Interview Survey.
Adv Data 1991 Jul 1;(204):1-12.
Hardy AM, Dawson DA. HIV antibody testing among adults in the
United States: data from 1988 NHIS. Am J Public Health 1990
May;80(5):586-9.
Hatzidimitriou K, Kontopoulou I, Mandalaki T, Renieri N,
Sofroniadou K, Politi C, Loizou K, Spiliotopoulou I, Gialeraki A,
Panayotopoulou K, et al. HIV seropositivity in Greek blood
donors (1985-1990) [letter]. Vox Sang 1991;61(3):215-6.
Haukenes G, Shao J, Mhalu F, Nome S, Sam NE. The AIDS epidemic
in Tanzania: rate of spread of HIV in blood donors and pregnant
women in Dar es Salaam. Scand J Infect Dis 1992;24(6):701-6.
Havlichek DH Jr, Greenman E, Plaisier K. High prevalence of
historical risk factors for blood-borne infections among
inpatients at three community hospitals. Am J Infect Control
1991 Apr;19(2):67-72.
Hayashi PH, Flynn N, McCurdy SA, Kuramoto IK, Holland PV, Zeldis
JB. Prevalence of hepatitis C virus antibodies among patients
infected with human immunodeficiency virus. J Med Virol 1991
Mar;33(3):177-80.
Heneine W, Lerche NW, Woods T, Spira T, Liff JM, Eley W, Yee JL,
Kaplan JE, Khabbaz RF. The search for human infection with
simian type D retroviruses. J Acquir Immune Defic Syndr 1993
Sep;6(9):1062-6.
Henrion R, Henrion-Geant E, Mandelbrot L. [Routes of HIV
infection in a pregnant population in metropolitan France:
evolution over a three year period]. Presse Med 1991 Sep
21;20(29):1365-8. (Fre).
Hermann DHJ. AIDS and the law. In: Reamer FC, editor. AIDS and
ethics. New York: Columbia University Press; 1991. p. 277-309.
Hernigou P, Kergrohen F, Fevrier MJ, Goutallier D. [The risk of
transmission of HIV virus during orthopedic surgery and its
prevention]. Rev Rhum Mal Osteoartic 1991 Jun;58(6):427-31.
(Fre).
Hernigou P, Kergrohen F, Julieron A, Goutallier D, Beaujan F.
[HIV virus and orthopedic surgery]. Rev Chir Orthop Reparatrice
Appar Mot 1993;79(1):5-12. (Fre).
Herr V, Ambruso D, Fairfax M, Neumann A, Swanson P, Lee H.
Transfusion-associated transmission of human T-lymphotropic virus
types I and II: experience of a regional blood center.
Transfusion 1993 Mar;33(3):208-11.
Hessol NA, Koblin BA, van Griensven GJ, Bacchetti P, Liu JY,
Stevens CE, Coutinho RA, Buchbinder SP, Katz MH. Progression of
human immunodeficiency virus type 1 (HIV-1) infection among
homosexual men in hepatitis B vaccine trial cohorts in Amsterdam,
New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994
Jun 1;139(11):1077-87.
Heymann SJ, Brewer TF. The infectious risks of transfusions in
the United States: a decision-analytic approach. Am J Infect
Control 1993 Aug;21(4):174-82.
Heymann SJ, Brewer TF, Fineberg HV, Wilson ME. How safe is safe
enough? New infections and the U.S. blood supply [editorial].
Ann Intern Med 1992 Oct 1;117(7):612-4. Comment on: Ann Intern
Med 1992 Oct 1;117(7):554-9. Comment in: Ann Intern Med 1993 Apr
1;118(7):574-5.
Hickman M, Mortimer JY, Rawlinson VI. Donor screening for HIV:
how many false negatives? [letter]. Lancet 1988 May
28;1(8596):1221.
Hilfenhaus J, Weidmann E. Fibrin glue safety: inactivation of
potential viral contaminants by pasteurization of the human
plasma components. Arzneimittelforschung 1985;35(11):1617-9.
Hilgartner M. AIDS in the transfusion recipient. Pediatr Clin
North Am 1991 Feb;38(1):121-31.
Hilgartner M. Results of the transfusion safety study. Ann
Hematol 1994;68 Suppl 3:S59.
Hilgartner MW. AIDS in the transfused patient. Am J Dis Child
1987 Feb;141(2):194-8.
Hilgartner MW, Buckley JD, Operskalski EA, Pike MC, Mosley JW.
Purity of factor VIII concentrates and serial CD4 counts. The
Transfusion Safety Study Group. Lancet 1993 May
29;341(8857):1373-4.
Hilgartner MW, Donfield SM, Willoughby A, Contant CF Jr, Evatt
BL, Gomperts ED, Hoots WK, Jason J, Loveland KA, McKinlay SM, et
al. Hemophilia growth and development study. Design, methods,
and entry data. Am J Pediatr Hematol Oncol 1993
May;15(2):208-18.
HIV antibody screening of blood donations 1987-1989. Wkly
Epidemiol Rec 1990 Oct 26;65(43):330-1. (Eng, Fre).
HIV antibody testing in children. Infectious Diseases and
Immunization Committee, Canadian Paediatric Society. Can Med
Assoc J 1993 Mar 1;148(5):759-64. (Eng, Fre).
[HIV screening of pregnant women and blood donors].
Lakartidningen 1993 May 12;90(19):1851. (Swe).
HIV testing of transfusion recipients. Connecticut State Medical
Society Committee on Organ and Tissue Transfers. Conn Med 1990
Apr;54(4):217-8.
Hoerni B. [Multidisciplinary consultation. A diagnosis of AIDS].
Bull Cancer (Paris) 1990;77(10):1037-47. (Fre).
Hogman C. [HIV and ethics--information and disinformation].
Lakartidningen 1992 Oct 7;89(41):3341-2. (Swe).
Hogman CF, Messeter L. [Discrepancies in the statistics of HIV-
positive persons should be corrected (letter)]. Lakartidningen
1993 May 12;90(19):1839. (Swe).
Holland PV, Richards CA, Teghtmeyer JR, Douville CM, Carlson JR,
Hinrichs SH, Pedersen NC. Anti-HTLV-III testing of blood donors:
reproducibility and confirmability of commercial test kits.
Transfusion 1985 Jul-Aug;25(4):395-7.
Holman RC, Chorba TL, Clarke MJ, Evatt BL. Epidemiology of AIDS
in females with hemophilia and other chronic bleeding disorders
in the United States: comparisons with males with chronic
bleeding disorders and AIDS and with nonhemophilic female blood-
transfusion recipients with AIDS. Am J Hematol 1992
Sep;41(1):19-23.
Horowitz B. Blood protein derivative viral safety: observations
and analysis. Yale J Biol Med 1990 Sep-Oct;63(5):361-9.
Horowitz B. Inactivation of viruses found with plasma proteins.
Biotechnology 1991;19:417-30.
Horowitz B, Rywkin S, Margolis-Nunno H, Williams B, Geacintov N,
Prince AM, Pascual D, Ragno G, Valeri CR, Huima-Byron T.
Inactivation of viruses in red cell and platelet concentrates
with aluminum phthalocyanine (AIPc) sulfonates. Blood Cells
1992;18(1):141-9; discussion 150.
Horowitz B, Williams B, Rywkin S, Prince AM, Pascual D, Geacintov
N, Valinsky J. Inactivation of viruses in blood with aluminum
phthalocyanine derivatives. Transfusion 1991 Feb;31(2):102-8.
Hosoi T. [Summary of the Educational Seminar at the 38th
Congress of Japan Society of Blood Transfusion]. Rinsho Byori
1991 Mar;Suppl 88:410-3. (Jpn).
Houweling H. [Iatrogenic HIV infection]. Ned Tijdschr Geneeskd
1993 Apr 3;137(14):701-6. Published errata appear in Ned
Tijdschr Geneeskd 1993 May 8;137(19):984 and 1993 Dec
25;137(52):2744. (Dut).
HTLV-I--a screen too many? [editorial]. Lancet 1990 Nov
10;336(8724):1161. Comment in: Lancet 1990 Dec
15;336(8729):1517.
Human immunodeficiency virus infection in the United States.
MMWR Morb Mortal Wkly Rep 1987 Dec 18;36(49):801-4.
Human immunodeficiency virus infection in the United States: a
review of current knowledge. MMWR Morb Mortal Wkly Rep 1987 Dec
18;36 Suppl 6:1-48. Published erratum appears in MMWR 1988 Aug
12;37(31):479.
Human immunodeficiency virus infection in transfusion recipients
and their family members. MMWR Morb Mortal Wkly Rep 1987 Mar
20;36(10):137-40.
Human immunodeficiency virus infection transmitted from an organ
donor screened for HIV antibody--North Carolina. MMWR Morb
Mortal Wkly Rep 1987 May 29;36(20):306-8.
Human T-lymphotropic virus type III/lymphadenopathy-associated
virus antibody testing at alternate sites. MMWR Morb Mortal Wkly
Rep 1986 May 2;35(17):284-7.
Hwang LY, Beasley RP, Busch MP, Lane PK, Vyas GN. Human
immunodeficiency virus seroprevalence among blood product
recipients in San Francisco before transfusion. Transfusion 1989
Feb;29(2):113-8.
Hyslop A, Ha B, Miller H, Sandler SG, Fang C. Detection of HIV-2
antibody in HTLV-I-II seropositive blood donors [abstract].
Transfusion 1991;31(8 Suppl):5s.
Immunologic and virologic status of multitransfused patients:
role of type and origin of blood products. By the AIDS-Hemophilia
French Study Group. Blood 1985 Oct;66(4):896-901.
The impact of routine HTLV-III antibody testing on public health.
Natl Inst Health Consens Dev Conf Consens Statement
1986;6(5):1-9.
Imrey HH, Williams BT. Alternative test sequences for HIV
screening of donated blood. J Med Syst 1989 Jun;13(3):177-86.
Irani MS, Dudley AW Jr, Lucco LJ. Case of HIV-1 transmission by
antigen-positive, antibody-negative blood [letter]. N Engl J Med
1991 Oct 17;325(16):1174-5. Comment on: N Engl J Med 1990 Nov
8;323(19):1308-12 and N Engl J Med 1990 Nov 8;323(19):1312-7.
Isarangkura P, Mahaphan W, Chiewsilp P, Chuansumrit A, Hathirat
P. HIV transmission by seronegative blood components: report of
2 probable cases. Vox Sang 1993;65(2):114-6.
Jackson B, Hanson M, Kwok S, Stramer S, Balfour HH Jr, MacDonald
K. HIV infection in western blot indeterminate blood donors
[abstract]. Int Conf AIDS 1989 Jun 4-9;5:345 (abstract no.
T.B.P.348).
Jackson JB. The polymerase chain reaction in transfusion
medicine. Transfusion 1990 Jan;30(1):51-7.
Jackson JB, MacDonald KL, Cadwell J, Sullivan C, Kline WE, Hanson
M, Sannerud KJ, Stramer SL, Fildes NJ, Kwok SY, et al. Absence
of HIV infection in blood donors with indeterminate western blot
tests for antibody to HIV-1. N Engl J Med 1990 Jan
25;322(4):217-22.
Jacobson MA, Peiperl L, Volberding PA, Porteous D, Toy PT, Feigal
D. Red cell transfusion therapy for anemia in patients with AIDS
and ARC: incidence, associated factors, and outcome. Transfusion
1990 Feb;30(2):133-7.
Jaffe HW, Francis DP, McLane MF, Cabradilla C, Curran JW,
Kilbourne BW, Lawrence DN, Haverkos HW, Spira TJ, Dodd RY, et al.
Transfusion-associated AIDS: serologic evidence of human T-cell
leukemia virus infection of donors. Science 1984 Mar
23;223(4642):1309-12.
Jaffe HW, Sarngadharan MG, DeVico AL, Bruch L, Getchell JP,
Kalyanaraman VS, Haverkos HW, Stoneburner RL, Gallo RC, Curran
JW. Infection with HTLV-III/LAV and transfusion-associated
acquired immunodeficiency syndrome. Serologic evidence of an
association. JAMA 1985 Aug 9;254(6):770-3.
Janssen RS, Osame M, Igata A, Kubota H, Nishitani H, Khabbaz RF.
HTLV-I associated myelopathy (HAM) is associated with blood
transfusion [abstract]. Neurology 1989;39(3 Suppl 1):382.
Janvier D, Reviron M, Reviron J. False negative results in a
competitive immunoassay for anti-HIV-antibodies due to the
presence of rheumatoid factors. Vox Sang 1989;56(4):237-42.
Jason J, Hilgartner M, Holman RC, Dixon G, Spira TJ, Aledort L,
Evatt B. Immune status of blood product recipients. JAMA 1985
Feb 22;253(8):1140-5.
Jason J, Holman RC, Dixon G, Lawrence DN, Bozeman LH, Chorba TL,
Tregillus L, Evatt BL. Effects of exposure to factor
concentrates containing donations from identified AIDS patients.
A matched cohort study. JAMA 1986 Oct 3;256(13):1758-62.
Jason JM, McDougal JS, Cabradilla C, Kalyanaraman VS, Evatt BL.
Human T-cell leukemia virus (HTLV-I) p24 antibody in New York
City blood product recipients. Am J Hematol 1985
Oct;20(2):129-37.
Jett JR, Kuritsky JN, Katzmann JA, Homburger HA. Acquired
immunodeficiency syndrome associated with blood-product
transfusions. Ann Intern Med 1983 Nov;99(5):621-4.
Ji Y. [Selection of methods for HIV screening of donors' sera
and blood products]. Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao
1991 Dec;13(6):408-11. (Chi).
Jimenez Romano R, Gimeno Ortiz A. [Retrovirus HIV-1 and HIV-2
infection in populations at risk. Estremadura]. Rev Sanid Hig
Publica (Madr) 1991 May-Jun;65(3):239-46. (Spa).
Joint statement on acquired immune deficiency syndrome (AIDS)
related to transfusion. Transfusion 1983 Mar-Apr;23(2):87-8.
Jones DS, Byers RH, Bush TJ, Oxtoby MJ, Rogers MF. Epidemiology
of transfusion-associated acquired immunodeficiency syndrome in
children in the United States, 1981 through 1989. Pediatrics
1992 Jan;89(1):123-7.
Jordan WC. Blood testing: an irrational decision [letter]. J
Natl Med Assoc 1987 Aug;79(8):801, 805.
Joyce ML, Krentler KA, Dietrich NS. Recruiting blood donors in
view of AIDS: what ambulatory care facilities need to understand.
J Ambulatory Care Manage 1989 Aug;12(3):28-35.
Jullien AM, Courouce AM, Richard D, Favre M, Lefrere JJ, Habibi
B. Transmission of HIV by blood from seronegative donors
[letter]. Lancet 1988 Nov 26;2(8622):1248-9.
Kager PA. [HIV-infection and the international traveler. I. The
non-HIV-infected traveler]. Ned Tijdschr Geneeskd 1991 Jun
8;135(23):1032-4. (Dut).
Kaiser V. [AIDS-related legal questions in trauma surgery].
Aktuelle Traumatol 1994 Feb;24(1):35-7. (Ger).
Kakaiya RM, Cable RG, Keltonic J. Look back: the status of
recipients of blood from donors subsequently found to have
antibody to HIV [letter]. JAMA 1987 Mar 6;257(9):1176-7.
Kalbfleisch JD, Lawless JF. Estimating the incubation time
distribution and expected number of cases of transfusion-
associated acquired immune deficiency syndrome. Transfusion 1989
Oct;29(8):672-6.
Kallings LO. HIV infection in the nineties. Vaccine
1993;11(5):525-8.
Kalyanaraman VS, Cabradilla CD, Getchell JP, Narayanan R, Braff
EH, Chermann JC, Barre-Sinoussi F, Montagnier L, Spira TJ, Kaplan
J, et al. Antibodies to the core protein of lymphadenopathy-
associated virus (LAV) in patients with AIDS. Science 1984 Jul
20;225(4659):321-3.
Kamihira S. [Development of blood products--the status and
appropriate application of blood transfusion]. Nippon Rinsho
1991 Dec;49 Suppl:799-804. (Jpn).
Kaplan HS, Kleinman SH. AIDS: blood donor studies and screening
programs. Prog Clin Biol Res 1985;182:297-308.
Kaplan M. Human retroviruses: a common virology. Transfus Med
Rev 1989 Jan;3(1 Suppl 1):4-8.
Keller KM, Bambauer C, Wirth S, Queisser-Luft A, Falke D, Baumann
W. [Hepatitis A, B, CMV, EBV and HIV infections in premature and
term newborn infants following polytransfusion]. Monatsschr
Kinderheilkd 1990 Sep;138(9):611-4. (Ger).
Kennedy M, Petersen L, Doll L. Five-year trends in HIV
seroprevalence and risk behaviors among U.S. blood donors: a
multicenter study [abstract]. Int Conf AIDS 1993 Jun
6-11;9(2):737 (abstract no. PO-C21-3118).
Kerman RH, van Buren CT, Lewis RM, Frazier OH, Cooley D, Kahan
BD. The impact of HLA A, B, and DR blood transfusions and immune
responder status on cardiac allograft recipients treated with
cyclosporine. Transplantation 1988 Feb;45(2):333-7.
Kerouedan D, Bontez W, Bondurand A, Abisse S, Konate S. [Blood
transfusions in Africa during the AIDS epidemic. Condition of
localities and perspectives in the Ivory Coast]. Sante 1994 Jan-
Feb;4(1):37-42. (Fre).
Kessler D, Georges-Yates E, Bianco C. Impact of direct questions
about HIV risk of predonation deferrals [abstract]. Transfusion
1992;32(8 Suppl):67s.
Khabbaz RF, Heneine W, Grindon A, Hartley TM, Shulman G, Kaplan
JE. Are indeterminate HTLV serologic results in USA blood donors
due to HTLV-Ior HTLV-II? [abstract]. Transfusion 1991;31(8
Suppl):41s.
Kimura T. [Blood transfusion. (2)]. Kanagawa Shigaku 1990
Sep;25(2):257-8. (Jpn).
King SM, McCrindle BW, Fearon M, Major C, Cook D. Results of the
HIV information project for transfusion recipients at the
Hospital for Sick Children--Toronto, Ontario. Can Commun Dis Rep
1994 May 30;20(10):77-80. (Eng, Fre).
Klein G. [Possibilities for avoiding homologous blood
transfusion in surgical interventions]. Unfallchirurgie 1992
Oct;18(5):280-4. (Ger).
Klein RS, Spivak M, Dubler NN, Mohandas K. Knowledge about AIDS
and testing for HIV infection among New York City blood donors
[letter]. AIDS 1989 Apr;3(4):243-4.
Kleinman S. The significance of HIV-1-indeterminate western blot
results in blood donor populations. Arch Pathol Lab Med 1990
Mar;114(3):298-303.
Kleinman S, Anton-Guirigis H, Culver BD, Taylor TH, Prince HE,
Kaplan HS. Anti-HTLV III ELISA and Western blot testing in a
blood donor population: implications for donor notification. Vox
Sang 1986;51(2):143-7.
Kleinman S, Fitzpatrick L, Secord K, Wilke D. Follow-up testing
and notification of anti-HIV Western blot atypical
(indeterminant) donors. Transfusion 1988 May-Jun;28(3):280-2.
Kleinman SH, Niland JC, Azen SP, Operskalski EA, Barbosa LH,
Chernoff AI, Edwards VM, Lenes BA, Marshall GJ, Nemo GJ, et al.
Prevalence of antibodies to human immunodeficiency virus type 1
among blood donors prior to screening. The Transfusion Safety
Study/NHLBI Donor Repository. Transfusion 1989 Sep;29(7):572-80.
Kleinman Y, Yust I, Maayan S, Rave D, Merdler C, Michaeli D,
Schlesinger M. Transmission of acquired immune deficiency
syndrome (AIDS) by a blood transfusion given in 1979 in Israel.
Isr J Med Sci 1986 May;22(5):404-7.
Knodler B, Kuhnl P. [HIV antigen test of blood donors].
Infusionsther Transfusionsmed 1993 Jun;20 Suppl 2:10-1. (Ger).
Knodler B, Kuhnl P, Roos D, Courouce AM. [Comparative study of 8
combined HIV-1,2-antibody tests]. Beitr Infusionther
1991;28:9-12. (Ger).
Knutsen AP, Bouhasin JD, Joist JH, Scrivner D, Mueller KR, Gioia
K, Janney S. Decrease of CD4 cell number and function in HIV-
seropositive hemophiliacs in a longitudinal study. Ann Allergy
1989 Sep;63(3):189-94.
Knuver-Hopf J, Mohr H, Beyer J, Lambrecht B, Mix D, Rubsamen-
Waigmann H, Schmitt H. HIV-2 antibody testing of blood donors
with doubtful immunoblot results for HIV-1. Blut 1989
Mar;58(3):155-7.
Koblin BA, Morrison JM, Taylor PE, Stoneburner RL, Stevens CE.
Mortality trends in a cohort of homosexual men in New York City,
1978-1988. Am J Epidemiol 1992 Sep 15;136(6):646-56.
Koblin BA, Taylor PE, Rubinstein P, Stevens CE. Effect of
duration of hepatitis B virus infection on the association
between human immunodeficiency virus type-1 and hepatitis B viral
replication. Hepatology 1992 Apr;15(4):590-2.
Koch MA, Schwartlander B, Kirschner W. [Blood donors as the
sentinel population for sexually transmissible diseases--results
of a sociodemographic study and survey of sexual behavior].
Gesundheitswesen 1993 Oct;55(10):504-13. (Ger).
Koepke MD, Levey SM, Koepke JA. A medicolegal evaluation of
directed blood donation. AIDS Public Policy J 1988
Summer;3(3):4-10.
Kohlhof A, Flessenkamper S. Tenth case of HIV transmission after
plasma donation [letter]. Lancet 1988 Oct 22;2(8617):965.
Koop CE. Surgeon General's report on acquired immune deficiency
syndrome. JAMA 1986Nov 28;256(20):2783-9.
Krasinski K, Borkowsky W, Holzman RS. Prognosis of human
immunodeficiency virus infection in children and adolescents.
Pediatr Infect Dis J 1989 Apr;8(4):216-20.
Kretschmer V. [Risks of infection caused by blood and blood
products with reference to the so-called AIDS scandal
(editorial)]. Infusionsther Transfusionsmed 1993
Dec;20(6):286-90. (Ger).
Kruskall MS, Umlas J. Acquired immunodeficiency syndrome and
directed blood donations. A dilemma for American medicine. Arch
Surg 1988 Jan;123(1):23-5.
Kubanek B, Cardoso M, Gluck D, Koerner K. [Risk of infection
transmission by blood components]. Infusionsther Transfusionsmed
1993 Apr;20(1-2):54-9. (Ger).
Kuehnl P, Roggendorf M, Stangel W, Seidl S, Laufs R, Sibrowski W,
Bornhoevd K, Polywka S, Kalmar G. HCV antibodies in NANBH
patients and members of HIV risk groups pilot study. Beitr
Infusionther 1990;26:30-2. (Ger).
Kwok S, Lipka JJ, McKinney N, Kellogg DE, Poiesz B, Foung SK,
Sninsky JJ. Low incidence of HTLV infections in random blood
donors with indeterminate western blot patterns. Transfusion
1990 Jul-Aug;30(6):491-4.
Lahmann N. [Hemophilia and AIDS]. Wiss Z Martin Luther Univ
Halle Wittenberg Math Naturwiss Reihe 1990;39(3):162. (Ger).
Lambert DC. [Prospects of the cost of AIDS-related death in
France (1970-2020)]. Cah Sociol Demogr Med 1993 Jul-
Sep;33(3):249-87. (Fre).
Lambin P, Desjobert H, Debbia M, Fine JM, Muller JY. Serum
neopterin and beta 2-microglobulin in anti-HIV positive blood
donors [letter]. Lancet 1986 Nov 22;2(8517):1216.
Lange JM, van den Berg H, Dooren LJ, Vossen JM, Kuis W, Goudsmit
J. HTLV-III/LAV infection in nine children infected by a single
plasma donor: clinical outcome and recognition patterns of viral
proteins. J Infect Dis 1986 Jul;154(1):171-4.
Larsen MO. [AIDS-risk and blood transfusion (letter)]. Ugeskr
Laeger 1994 Feb 28;156(9):1325. (Dan).
Laurence J, Brun-Vezinet F, Schutzer SE, Rouzioux C, Klatzmann D,
Barre-Sinoussi F, Chermann JC, Montagnier L. Lymphadenopathy-
associated viral antibody in AIDS. Immune correlations and
definition of a carrier state. N Engl J Med 1984 Nov
15;311(20):1269-73.
Lawrence DN. A review of clinical studies evaluating the
efficacy of HIV inactivation methods. Prog Clin Biol Res
1990;324:151-60.
Lawrence DN, Jason JM, Bouhasin JD, McDougal JS, Knutsen AP,
Evatt BL, Joist JH. HTLV-III/LAV antibody status of spouses and
household contacts assisting in home infusion of hemophilia
patients. Blood 1985 Sep;66(3):703-5.
Le Pont F, Costagliola D, Rouzioux C, Valleron AJ. Evaluation of
the potential benefit of routine blood donor screening for HIV
P24 antigen [abstract]. Int Conf AIDS 1992 Jul 19-24;8(3):173
(abstract no. PuC 8122).
Le Pont F, Massari V, Jullien AM, Costagliola D, Valleron AJ.
Anti-HBc testing can decrease the residual risk of transfusion-
related HIV transmission by more than one third [letter]. Vox
Sang 1990;59(4):248-50.
Leads from the MMWR. Apparent transmission of human T-
lymphotropic virus type III/lymphadenopathy-associated virus from
child to mother providing health care. JAMA 1986 Feb
28;255(8):1005, 1009-10.
Leads from the MMWR. HIV human immunodeficiency virus infection
transmitted from an organ donor screened for HIV antibody--North
Carolina. JAMA 1987 Jul 17;258(3):308-9.
Leads from the MMWR. Human immunodeficiency virus infection in
transfusion recipients and their family members. JAMA 1987 Apr
10;257(14):1860-1.
Leads from the MMWR. Prevalence of human immunodeficiency virus
antibody in U.S. active-duty military personnel, April 1988.
JAMA 1988 Sep 2;260(9):1205-6.
Leads from the MMWR. Revised definition of persons who should
refrain from donating blood and plasma. JAMA 1985 Oct
11;254(14):1886.
Learmont J, Tindall B, Evans L, Cooper DA. Long term
asymptomatic infection in a group of blood transfusion recipients
with a single common donor [abstract]. Int Conf AIDS 1992 Jul
19-24;8(3):173 (abstract no. PuC 8123).
Lee CA, Phillips A, Elford J, Miller EJ, Bofill M, Griffiths PD,
Kernoff PB. The natural history of human immunodeficiency virus
infection in a haemophilic cohort. Br J Haematol 1989
Oct;73(2):228-34.
Lee HH, Sherwood WC, Smith DE, Tegtmeier GE, Fernando LP, Fang
CT, Kleinman SH. HTLV-1 and HTLV-II infection in U.S. blood
donors in associated with different risk factors [abstract]. Int
Conf AIDS 1990 Jun 20-23;6(1):195 (abstract no. Th.A.302).
Lee HH, Swanson P, Rosenblatt JD, Chen IS, Sherwood WC, Smith DE,
Tegtmeier GE, Fernando LP, Fang CT, Osame M, et al. Relative
prevalence and risk factors of HTLV-I and HTLV-II infection in US
blood donors. Lancet 1991 Jun 15;337(8755):1435-9.
Lee TH, el-Amad Z, Reis M, Adams M, Donegan EA, O'Brien TR, Moss
AR, Busch MP. Absence of HIV-1 DNA in high-risk seronegative
individuals using high-input polymerase chain reaction. AIDS
1991 Oct;5(10):1201-7.
Lee TH, Reis M, Busch MP. PCR quantitation of HIV-infected cell
burden pre-post-seroconversion [abstract]. Transfusion 1992;32(8
Suppl):57s.
Lee TH, Sunzeri FJ, Tobler LH, Williams BG, Busch MP.
Quantitative assessment of HIV-1 DNA load by coamplification of
HIV-1 gag and HLA-DQ-alpha genes. AIDS 1991 Jun;5(6):683-91.
Lefrere JJ, Courouce AM, Lucotte G, Boitard C, Kaplan C, Nicolas
JC, Bricout F, Lambin P, Doinel C, Muller JY, et al. Follow-up
of subjects with isolated and persistent anti-core (anti-p24 or
anti-p17) antibodies to HIV. AIDS 1988 Aug;2(4):287-90.
Lefrere JJ, Courouce AM, Rouger P, Duedari N, Elghouzzi MH. p24
antigen and HIV screening [letter]. Lancet 1992 Apr
18;339(8799):999-1000.
Lefrere JJ, de Montalembert M, Mariotti M, Girot R, Salmon C,
Rouger P, Rey J. Absence of HIV DNA sequences in seronegative
polytransfused thalassemic patients. Vox Sang 1990;59(4):218-21.
Lefrere JJ, Elghouzzi MH, Paquez F, N'Dalla J, Nubel L.
Interviews with anti-HIV-positive individuals detected through
the systematic screening of blood donations: consequences on
predonation medical interview. Vox Sang 1992;62(1):25-8.
Lefrere JJ, Jullien AM. [Practical approach to the discovery of
a positive HIV serology in a blood donor]. Rev Fr Transfus
Hemobiol 1991 Jul;34(4):295-304. (Fre).
Lefrere JJ, Mariotti M, Thauvin M. B19 parvovirus DNA in
solvent/detergent-treated anti-haemophilia concentrates. Lancet
1994 Jan 22;343(8891):211-2. Comment in: Lancet 1994 Mar
26;343(8900):798.
Lefrere JJ, Paquez F, Duc A, Rouger P, Salmon C. [Interviews
with HIV seropositive subjects identified at the time of blood
donation: consequences for pre-donation interviews]. Rev Fr
Transfus Hemobiol 1990 Jul;33(4):239-48. (Fre).
Lefrere JJ, Richard D, Courouce AM, Cotte G, Guillard A, Mesnier
F, Aubertin J, Morlat P, Noel L, Smilovici W, et al. Risk
factors of HIV-seropositive subjects detected through blood
donation in France, 1985-1988 [letter]. Transfusion 1989
Jan;29(1):84-6.
Lefrere JJ, Rouger P. [Transfusion and AIDS? Who should be
transfused?]. Ann Chir 1990;44(7):489-92. (Fre).
Leitman SF, Klein HG, Melpolder JJ, Read EJ, Esteban JI, Leonard
EM, Harvath L, Shih JW, Nealon R, Foy J, et al. Clinical
implications of positive tests for antibodies to human
immunodeficiency virus type 1 in asymptomatic blood donors. N
Engl J Med 1989 Oct 5;321(14):917-24.
Lemmel EM. [Federal public health service--quo vadis?].
Fortschr Med 1993 Nov 20;111(32):28-30. (Ger).
Leon de Gonzalez G, Hernandez T, Arias F, Celis S, Acosta V,
Semprun O, Lugo de Moron M. [HIV and blood donors: past, present
and future]. Sangre (Barc) 1994 Feb;39(1):15-21. (Spa).
Levine C, Mayer K, Goldfinger D, Reiss RF, Pindyck J. The
community blood supply and patients' choice. [Introduction and
set of three articles on the pros and cons of the current U.S.
community blood supply system versus directed blood donations].
Hastings Cent Rep 1987 Apr;17(2):5-10.
Lewis WF, Dodd RY. Trends in prevalence of HIV infection among
USA blood donors [abstract]. Transfusion 1992;32(8 Suppl):56s.
Libert MH, Verdonk G. [Sexually transmissible diseases and
medical ethics]. Acta Urol Belg 1993 Jan-Jun;61(1-2):71-80.
(Fre).
Ligtenberg PC, Hoepelman IM, Vrehen HM, Borleffs JC. [Zidovudine
treatment and need of blood transfusion in patients with AIDS].
Ned Tijdschr Geneeskd 1991 Jan 26;135(4):130-3. (Dut).
Lin L, Londe H, Hanson CV, Wiesehahn G, Isaacs S, Cimino G,
Corash L. Photochemical inactivation of cell-associated human
immunodeficiency virus in platelet concentrates. Blood 1993 Jul
1;82(1):292-7.
Lipton KS. Blood donor services and liability issues relating to
acquired immune deficiency syndrome. J Leg Med 1986
Jun;7(2):131-86.
LoBello SG. Differences between blood donors and nondonors in
AIDS-related attitudes. Psychol Rep 1990 Jun;66(3 Pt 1):867-70.
Locke SE, Kowaloff HB, Hoff RG, Safran C, Popovsky MA, Cotton DJ,
Finkelstein DM, Page PL, Slack WV. Computer-based interview for
screening blood donors for risk of HIV transmission. JAMA 1992
Sep 9;268(10):1301-5. Comment in: JAMA 1993 Mar
24-31;269(12):1505-6.
Locke SE, Kowaloff HB, Hoff RG, Safran C, Popovsky MA, Cotton DJ,
Finkelstein DM, Page PL, Slack WV. Computer interview for
screening blood donors for risk of HIV transmission. MD Comput
1994 Jan-Feb;11(1):26-32.
Loiacono BR, Carter GR, Carter CS, Leitman SF, Klein HG.
Efficacy of various methods of confidential unit exclusion in
identifying potentially infectious blood donations. Transfusion
1989 Nov-Dec;29(9):823-6. Comment in: Transfusion 1990
Sep;30(7):668-9 and Transfusion 1991 Mar-Apr;31(3):286-7.
London WT. Epidemiologic lessons from viral hepatitis B. Ann N
Y Acad Sci 1984;437:100-5.
Louis JP, Trebucq A, Hengy C, Danyod M, Fatchou G, Tirandibaye N,
Granga D, Buriot D, Meslet B, Milleliri JM, et al. [Epidemiology
of infections caused by HIV-1, HIV-2 and HTLV-1 in the republic
of Chad]. Bull Soc Pathol Exot 1990;83(5):603-10. (Fre).
Loyau P. [AIDS: physicians condemned in French hemophiliac
scandal]. Sygeplejersken 1992 Nov 11;92(46):12-3. (Dan).
Loyau P. [AIDS--this century's medical scandal]. Sygeplejersken
1992 Aug 12;92(33):6-12. (Dan).
Lu W, Shih JW, Tourani JM, Eme D, Alter HJ, Andrieu JM. Lack of
isolate-specific neutralizing activity is correlated with an
increased viral burden in rapidly progressing HIV-1-infected
patients. AIDS 1993 Nov;7 Suppl 2:S91-9.
Lucia JF, Garcia Aranda A. [Hemophilia and blood derivatives:
past and future (editorial)]. Med Clin (Barc) 1991 Mar
30;96(12):456-8. (Spa).
Lucia JF, Garcia Aranda A. [Incidence of seroconversion for the
human immunodeficiency virus in non-hemophiliac patients
receiving low doses of prothrombin complex factors (letter)].
Med Clin (Barc) 1991 Sep 28;97(10):398-9. (Spa).
Lui KJ, Darrow WW, Rutherford GW 3d. A model-based estimate of
the mean incubation period for AIDS in homosexual men. Science
1988 Jun 3;240(4857):1333-5.
Lui KJ, Lawrence DN, Morgan WM, Peterman TA, Haverkos HW, Bregman
DJ. A model-based approach for estimating the mean incubation
period of transfusion-associated acquired immunodeficiency
syndrome. Proc Natl Acad Sci U S A 1986 May;83(10):3051-5.
Lui KJ, Peterman TA, Lawrence DN, Allen JR. A model-based
approach to characterize the incubation period of paediatric
transfusion-associated acquired immunodeficiency syndrome. Stat
Med 1988 Mar;7(3):395-401.
Lusher JM, Operskalski EA, Aledort LM, Dietrich SL, Gjerset GF,
Hilgartner MW, Koerper MA, Pegelow CH, Lee H, Mosley JW. Risk of
human immunodeficiency virus type 1 infection among sexual and
nonsexual household contacts of persons with congenital clotting
disorders. Pediatrics 1991 Aug;88(2):242-9.
Luzzati R, Mengoli C, Dattoli R, Rossi E, Solbiati M, Bassetti D,
Della Gassa O, De Rossi A, Chieco-Bianchi L, Tridente G.
[Infections of HTLV III virus in Verona Italy]. G Mal Infett
Parassit 1986;38(4):393-5. (Ita).
Mac Kenzie WR, Davis JP, Peterson DE, Hibbard AJ, Becker G,
Zarvan BS. Multiple false-positive serologic tests for HIV,
HTLV-1, and hepatitis C following influenza vaccination, 1991.
JAMA 1992 Aug 26;268(8):1015-7.
Makris M. Safety of antithrombin III concentrate [letter].
Blood 1990 Aug 1;76(3):649-50. Comment on: Blood 1990 Jan
1;75(1):33-9.
Manns A, Blattner WA. The epidemiology of the human T-cell
lymphotrophic virus type I and type II: etiologic role in human
disease. Transfusion 1991 Jan;31(1):67-75.
Mansilla Bermenjo MJ, Marchan Carranza E, Carbayo Garcia JJ,
Moraleda Velasco P. [Geriatric AIDS: 2 new cases (letter)].
Aten Primaria 1994 Feb 15;13(2):98-9. (Spa).
Mariotti M, Rouger P, Thauvin M, Salmon C, Lefrere JJ. Failure
to detect evidence of human immunodeficiency virus type 1 (HIV-1)
infection by polymerase chain reaction assay in blood donors with
isolated core antibodies (anti-p24 or -p17) to HIV-1.
Transfusion 1990 Oct;30(8):704-6.
Matthews JL, Newman JT, Sogandares-Bernal F, Judy MM, Skiles H,
Leveson JE, Marengo-Rowe AJ, Chanh TC. Photodynamic therapy of
viral contaminants with potential for blood banking applications.
Transfusion 1988 Jan-Feb;28(1):81-3.
Maurer C, Kiehl W, Altmann D. [HIV prevalence and HIV incidence
in blood donors in Baden-Wurttemberg]. Beitr Infusionther
1993;31:5-9. (Ger).
Mayer A, Sunzeri F, Lee TH, Busch MP. Separation and detection
of DNA polynucleotides using capillary electrophoresis.
Application to detection of polymerase chain reaction-amplified
human immunodeficiency virus and HLA DNA. Arch Pathol Lab Med
1991 Dec;115(12):1228-34.
Mayo DJ, Rose AM, Matchett SE, Hoppe PA, Solomon JM, McCurdy KK.
Screening potential blood donors at risk for human
immunodeficiency virus. Transfusion 1991 Jun;31(5):466-74.
Mazurin AV, Karamov EV, Tsymbal IN, Chaplinskas SA, Plakhuta TG,
Vdovin VV. [Risk of HIV infection in children with hemophilia].
Pediatriia 1990;(5):96-7. (Rus).
McCleod MJ, Pecora AA, Sorbello AF, Condoluci D. Seronegative
acquired immunodeficiency syndrome (AIDS). J Am Osteopath Assoc
1991 Jan;91(1):72, 79-82.
McCullough J. The nation's changing blood supply system. JAMA
1993 May 5;269(17):2239-45.
McDougal JS, Jaffe HW, Cabridilla CD, Sarngadharan MG, Nicholson
JK, Kalyanaraman VS, Schable CA, Kilbourne B, Evatt BL, Gallo RC,
et al. Screening tests for blood donors presumed to have
transmitted the acquired immunodeficiency syndrome. Blood 1985
Mar;65(3):772-5.
McMahon CA, Dock NL, Lentz EB, Lamberson HV Jr. Atypical human
immunodeficiency virus immunoblot reactivity in blood donors
negative by screening assays [abstract]. Transfusion (Phila)
1988;28(6 Suppl):13s.
McNearney T, Hornickova Z, Kloster B, Birdwell A, Storch GA,
Polmar SH, Arens M, Ratner L. Evolution of sequence divergence
among human immunodeficiency virus type 1 isolates derived from a
blood donor and a recipient. Pediatr Res 1993 Jan;33(1):36-42.
Medley GF, Anderson RM, Cox DR, Billard L. Incubation period of
AIDS in patients infected via blood transfusion. Nature 1987 Aug
20-26;328(6132):719-21.
Medley GF, Billard L, Cox DR, Anderson RM. The distribution of
the incubation period for the acquired immunodeficiency syndrome
(AIDS). Proc R Soc Lond B Biol Sci 1988 Apr 22;233(1272):367-77.
Melbye M. [The Anders Jahre Prize for young researchers 1992.
HIV/AIDS--an epidemiological challenge]. Nord Med
1993;108(3):72-5. (Dan).
Melbye M. The natural history of human T lymphotropic virus-III
infection: the cause of AIDS. Br Med J (Clin Res Ed) 1986 Jan
4;292(6512):5-12.
Melief CJ, Goudsmit J. Transmission of lymphotropic retroviruses
(HTLV-I and LAV/HTLV-III) by blood transfusion and blood
products. Vox Sang 1986;50(1):1-11.
Mempel W. [Current focus: blood transfusion. Risks and problems
in blood transfusion]. Zentralbl Chir 1993;118(9):563-6. (Ger).
Mendelson DN, Sandler SG. A model for estimating incremental
benefits and costs of testing donated blood for human
immunodeficiency virus antigen (HIV-Ag). Transfusion 1990
Jan;30(1):73-5.
Menitove JE, Lewandowski C, Ashworth LW, Carey PM. Confidential
unit exclusion process continues to identify donors with an
increased frequency of HIV seropositivity [abstract].
Transfusion 1991;31(8 Suppl):69s.
Miller K, Donegan E, Curran P, Shelley TJ. Effects of
counselling on knowledge about HIV-1 among transfusion recipients
and their partners. Transfusion Safety Study Group. AIDS Care
1990;2(2):155-62.
Molaro GL. [Transfusion: risks and future prospects]. G Clin
Med 1990 Oct;71(10):547-59. (Ita).
Molina Moguel JL, Ruiz Illezcas R, Forsbach Sanchez S, Carreno
Alvarez S, Picco Diaz I. [Acquired immunodeficiency syndrome in
pediatric patients]. Pract Odontol 1990 Dec;11(12):31, 34, 36-7.
(Spa).
Moncharmont P, Voisin A, Kieger C, Chevre C. [Value of
information and responsibility of blood donors in the prevention
of transmission of the human immunodeficiency virus (letter)].
Presse Med 1991 Oct 5;20(31):1513. Published erratum appears in
Presse Med 1991 Oct 26;20(34):1690. (Fre).
Moraczewska Z, Seyfriedowa H, Kacperska E, Szata W, Mazurkiewicz
W, Babiuch L. [HIV-1 infection in blood donors and blood
recipients]. Przegl Epidemiol 1990;44(3):149-54. (Pol).
Morini A, Di Giusto M, Lambiasi A, Cantonetti G. [Pregnancy in
HIV positive women: psycho-emotional aspects. Study of 16 cases].
Minerva Ginecol 1993 Jan-Feb;45(1-2):39-46. (Ita).
Mosley JW. Antibody to HTLV-I-II among blood donors in four
cities of the United States [abstract]. Int Conf AIDS 1989 Jun
4-9;5:146 (abstract no. Th.A.P.32).
Mosley JW. Antibody to HTLV among blood donors in three cities
of the USA [abstract]. J Cell Biochem Suppl 1989;13 Pt B:307.
Mounanga M, Revangue BS. [HIV-1 seroprevalence in pregnant women
in Libreville (Gabon)]. J Gynecol Obstet Biol Reprod (Paris)
1993;22(5):509-12. (Fre).
Muganga N, Nkuadiolandu A, Mashako LM. [Clinical manifestations
of
